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ABSTRACT 
Mitochondria are vital to the proper growth and function of muscle cells since they’re 
responsible for the majority of ATP production used for cellular energy. Previous studies have 
investigated how differences in mitochondrial function affects feed efficiency (FE) in broilers 
phenotyped for High and Low FE. Low FE broilers have been shown to have increased levels of 
reactive oxygen species (ROS), thus contributing to higher levels of oxidative stress and damage 
seen in these birds. Global gene and protein expression studies conducted on breast muscle of the 
High FE and Low FE phenotypes have suggested that differences in mitochondrial function and 
hormone signaling play a role in feed efficiency. In mammalian muscle cells, hormones such as 
the neuropeptide orexin are known to affect mitochondrial function. Therefore, the focus in this 
study was to determine whether hormones can affect mitochondrial dynamics in avian muscle 
cells, compare the expression of genes involved in muscle growth and insulin signaling in the 
High FE and Low FE phenotypes, and determine whether hormone receptors are present in the 
mitochondria of avian muscle cells. The actions of hormones and their receptors play an 
important role in the regulation of growth and metabolism. Investigation of orexin expression in 
avian muscle cells revealed that the hormone and its receptor are expressed in muscle. Orexin 
was also shown to be secreted by muscle cells and caused differential expression of a number of 
mitochondrial-related genes. Based on predictions generated by the results obtained from global 
expression studies, qRT-PCR analysis revealed several differentially expressed genes between 
the High and Low FE phenotype that are associated with muscle growth/development and the 
insulin signaling pathway. Lastly, due to the lack of scientific literature concerning the 
expression of hormone receptors in the mitochondria of avian muscle cells, studies were 
conducted that do indicate the presence of receptors in muscle mitochondria. 
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1. INTRODUCTION 
 Mitochondria are essential to cellular growth, development, and function. These 
organelles account for ~90% of the ATP that is produced and used as energy to carry out 
numerous cellular actions (Lehninger et al., 1993). In addition to its role in energy production, 
mitochondria also function in regulating cell metabolism, antioxidant protection, heat 
production, and apoptosis among a number of other cellular processes. Therefore, the 
mitochondria are vital to the overall health and well-being of eukaryotic organisms. 
Mitochondrial dysfunction is typically caused by mutations in mitochondrial proteins that are 
encoded by either nuclear DNA or mitochondrial DNA (mtDNA), oxidative damage as a result 
of the production of reactive oxygen species, and the natural aging process. This can result in 
impaired growth and development, and a number of human diseases such as Parkinson’s disease, 
diabetes, and Alzheimer’s disease (Pieczenik and Neustadt, 2007).   
One research area of interest is the stimulation and enhancement of mitochondrial 
function due to the effects of hormones and their respective receptors on the organelle. When 
hormones bind to their receptors the complex serves as a transcription factor that has the ability 
to bind to DNA and activate or repress specific genes and signaling pathways. The activation of 
genes by hormones and their receptors typically occurs through binding to hormone response 
elements (HREs), which are DNA sequences located in the promoter region of the gene (Wu et 
al., 2001; Scheller and Sekeris, 2003). The positive effects of steroid and thyroid hormones on 
mammalian mitochondrial function have been well documented, as evidenced by increases in 
mitochondrial respiration, gene expression, and biogenesis (Weber et al., 2002; Bassett et al., 
2003; Dai et al., 2013; Liao et al., 2015)  One particular hormone of interest is the neuropeptide 
orexin, which has been shown to regulate a variety of physiological processes in mammals, 
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including energy and glucose homeostasis, lipid metabolism, heart rate and blood pressure, and 
food and water intake (Sakurai, 1999; Zhang et al., 2005; Tsuneki et al., 2012; Shen et al., 2013). 
In recent studies the hormone orexin has also been shown to regulate mitochondrial biogenesis in 
addition to brown adipose tissue differentiation and thermogenesis in mammals (Sellayah et al., 
2011; Swami, 2011). 
Hormonal effects on muscle growth, development, and enhanced mitochondrial function 
have been well-illustrated in mammals. However, comparatively little is known about the 
inherent distribution and function of hormones and their respective receptors in the tissues of 
avian species, and how they affect mitochondrial dynamics. It is possible that a clearer 
understanding of the interactions between hormone signaling and mitochondrial function in birds 
reared specifically for meat production (i.e. broilers) could be beneficial currently and in the 
future. This type of information could be valuable to the poultry industry, where cost effective 
meat production is a cornerstone of maintaining the industry’s viability. 
One persistent issue facing the poultry industry is how to raise broilers to market weight 
for meat production in an efficient manner that does not incur excessive costs. The cost of feed 
that is required to raise birds to market weight generally accounts for 70% of the total costs 
(Willems et al., 2013).  As a result, feed efficiency (FE), which is the amount of body weight 
gained over the amount of feed consumed (gain:feed), is very important when considering 
selection of animals with the desired production traits. Over the past several decades, vast 
improvements to FE and growth rate of birds within the poultry industry have been made due to 
improvements in genetic selection of animals and nutrition management, with as much as a 
300% increase in FE being observed (Havenstein et al., 1994; 2007). However, despite these 
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improvments in poultry production, there are still issues with variation both within and between 
strains of broilers.  
Prior research investigating broilers within the same genetic line that were phenotyped as 
having high or low FE showed that mitochondrial perturbations were a characteristic of the low 
FE phenotype. In studies conducted using isolated breast muscle and mitochondria isolated from 
duodenal tissue, low FE broilers displayed impaired mitochondrial function that occurred in the 
form of decreased respiratory chain coupling, increased electron leak from the electron transport 
chain, and increased hydrogen peroxide production (Bottje et al., 2002; Ojano-Dirain et al., 
2004). This formation of hydrogen peroxide by the mitochondria leads to the generation of 
reactive oxygen species (ROS) such as superoxide and hydroxyl radicals which cause damage to 
DNA, lipids and proteins. Subsequent analysis of various tissues from high and low FE broilers 
(breast muscle, gut, leg muscle, heart, liver, and lymphocytes) indicated that the low FE broilers 
had elevated levels of protein carbonyls, which are an indicator of protein oxidation and damage 
(Iqbal et al., 2004, 2005; Ojano-Dirain et al., 2005, 2007; Lassiter et al., 2006; Tinsley et al., 
2010). Based on these reports, the conclusion can be drawn that the low FE phenotype is more 
susceptible to the production of damaging oxygen radicals that occur as a result of defects in the 
mitochondrial electron transport chain. 
Even though high levels of ROS are very damaging to cellular components, at low levels 
these molecules are an important component of signal transduction and the control of cell growth 
and proliferation through control of physiological processes such as mitochondrial biogenesis, 
growth factor signaling, and insulin sensitivity (Finkel, 2011). As a result, changes in the levels 
of ROS can have an impact on the expression of genes and proteins. Based on this observation, 
breast muscle from the high and low FE broilers were subjected to analysis of global gene (Kong 
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et al., 2011; Bottje et al., 2012) and protein expression (Kong et al., 2016) in order to develop a 
more comprehensive understanding of how FE is chararcterized at the cellular level. 
Interpretation of the data generated from these global expression studies was performed using the 
online software program Ingenuity Pathway Analysis (IPA; http://apps.ingenuity.com) as a way 
to generate predictions that illustrate the genomic and proteomic networks that are associated 
with high and low FE. In the microarray analysis of gene expression, multiple aspects of 
hormone signaling were determined to be involved in FE. A number of genes that take part in the 
insulin signaling pathway (i.e. AMPK, PI3K, PDK1, S6K, mTORC1) were predicted to be 
upregulated in the high FE phenotype (Bottje et al., 2014). Subsequent analysis of the same 
genomic dataset also suggests that progesterone signaling within avian mitochondria is 
associated with the divergence of the high and low FE broiler phenotype (Bottje et al., 2017). 
Shotgun proteomic analysis of high and low FE breast muscle also points to hormone signaling 
as being involved in the determination of FE. In addition to enhanced mitochondrial expression 
in the high FE broilers, Kong et al. (2016) also identified several molecules involved in hormone 
signaling, such as insulin receptor, insulin like growth receptor 1, progesterone, and 
triiodothyronine (T3) as being activated in high FE broilers. The predictions based on these 
global expression datasets indicate that enhanced mitochondrial function and hormone signaling 
are characteristics of the high FE phenotype. 
Based on the results obtained from the global expression data, it would be interesting to 
see whether hormone signaling has a direct action on the expression and function of 
mitochondria in chickens. This has been studied in mammals, where receptors for steroid and 
thyroid hormones have been identified in the mitochondria (Demonakos et al., 1993; Dai et al., 
2013; Wrutniak-Cabello et al., 2001). Additionally, HREs for mammalian steroid and thyroid 
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hormones have also been identified within the mtDNA (Demonakos et al., 1995; Chen et al., 
2005; Psarra et al., 2006). The presence of hormone receptors and HREs in the mitochondrial 
genome enhances gene and protein expression, thus enhancing energy production and 
mitochondrial function. However, searches of the current literature do not report the presence of 
hormone receptors in avian species. If these receptors are present in avian mitochondria, it would 
give further insight into how function of the organelle is controlled and whether it is related to 
genetic traits such as FE. 
1.2 OBJECTIVES 
 The objectives of my research in this dissertation were to investigate if the presence of 
hormones and their respective receptors in avian muscle cells are involved in mitochondrial 
physiology, determine whether differences in FE can be partially attributed to differences in the 
expression of components of hormone signaling pathways, and to determine whether hormone 
receptors are present within the mitochondria of avian muscle cells. 
Specific objectives for this dissertation are as follows: 
1.        To investigate whether the orexin system is expressed in avian muscle and its potential    
role in the regulation of muscle mitochondrial dynamics, biogenesis, and function. 
2.        To conduct targeted analysis of genes involved in muscle development, protein synthesis, 
and energy metabolism; particularly genes in part of the myostatin and insulin signaling 
pathways that are differentially expressed in breast muscle obtained from broilers 
exhibiting a high or low FE phenotype. 
3.         To determine whether the mitochondrial hormone receptors for progesterone, estrogen, 
glucocorticoid, thyroid, and insulin are present in both an avian muscle cell line and 
intact avian muscle cells.  
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2. REVIEW OF THE LITERATURE 
2.1 OREXIN 
Orexin, which regulates wakefulness, energy homeostasis, and appetite/feeding behavior 
based on nutritional status, is a neuropeptide hormone that was originally discovered in the 
hypothalamus of rats by investigating orphan G protein-coupled receptors (de Lecea et al., 1998; 
Sakurai et al., 1998). Orphan receptors are those whose ligand and physiological actions are 
unknown (Stadel et al., 1997). The term orexin originates from the Greek word “orexis”, 
meaning appetite. There are two known orexin peptides (ORX-A and ORX-B), both of which are 
formed by proteolytic cleavage of the precursor prepro-orexin (Sakurai et al., 1998). The 
synonymous terms “hypocretin 1 and 2” were coined by de Lecea et al. (1998), where hypo 
refers to the peptide’s origin in the hypothalamus and cretin refers to the similarity of the 
peptide’s amino acid sequence with the gut hormone secretin. When initially discovered in rats, 
the precursor peptide prepro-orexin was shown to be a 130-residue polypeptide from which the 
mature peptides ORX-A and ORX-B were formed, with ORX-A containing 33 amino acids and 
a molecular weight 3.562 kDa and ORX-B containing 28 amino acids and a molecular weight of 
2.937 kDa (Sakurai et al., 1998). When comparing the two peptides, ORX-B was shown to be 
forty-six percent identical in amino acid sequence to ORX-A. However, when comparing 
mammalian species (human, rat, mouse, pig, and cow), the sequence and structure of both 
peptides is highly conserved (Sakurai, 1998). A number of studies have also shown that the 
structures of ORX-A and ORX-B in chicken and certain types of fish are conserved when 
compared to their mammalian counterparts (Shibahara et al., 1999; Alvarez and Sutcliffe, 2002; 
Sakurai, 2005; Tsujino and Sakurai, 2009).     
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2.1.1 OREXIN RECEPTORS 
ORX-A and ORX-B signal through the G protein-coupled receptors orexin receptor 1 
(ORXR1) and orexin receptor 2 (ORXR2). These two ubiquitously expressed receptors were first 
identified in human brain tissue through expressed sequence tags combined with database 
searching using tBLASTn (Soppet et al., 1996; Sakurai et al., 1998). In humans it has been 
shown that the amino acid sequence for ORXR1 and ORXR2 is more than sixty percent 
identical, making them more similar to each other than to other G protein-coupled receptors 
(Sakurai et al., 1998). The same study also showed that both receptors are highly conserved 
between humans and rats, with the sequence identity being greater than ninety percent for both. 
The two orexin peptides have different binding affinities for the two orexin receptors. ORX-A is 
able to bind to both receptors but has a higher affinity for ORXR1, while ORX-B binds to 
ORXR2 with the same affinity as ORX-A (Tsujino and Sakurai, 2009). Several studies have 
indicated that the binding of orexins to orexin receptors activates multiple G proteins. In studies 
conducted using humans (Karteris et al., 2001; Randeva et al., 2001) and rats (Karteris et al., 
2005), it was shown that the binding of ORXR2 activates Gi, Gs, Go, and Gq proteins in adrenal 
cortical tissue. It appears that the responses to orexin receptor signaling are highly diverse. The 
activation of the various G proteins can lead to a variety of cellular responses such as the 
regulation of protein/lipid kinases (Hepler and Gilman, 1992; Gautam et al., 1998). In the case of 
orexin stimulation activation of G proteins can lead to the excitation of neurons that affect the 
regulation of ion channels, the activation of signaling cascades that regulate the activity of 
adenylyl cyclase, phospholipases, and activation of cell death pathways (reviewed by Kukkonen, 
2013; Kukkonen and Leonard, 2014). 
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2.1.2 OREXIN EXPRESSION IN MAMMALIAN PERIPHERAL TISSUES 
As stated previously, orexin was initially discovered to be produced by neurons in the 
hypothalamus of rats. Additional studies have shown that the axons of these orexin-producing 
neurons are extensively distributed throughout the central nervous system (Peyron et al., 1998; 
Nambu et al., 1999; van den Pol, 1999), along with expression of both orexin receptors (Trivedi 
et al., 1998; Marcus et al., 2001). This indicates that the expression of orexin and its receptors is 
vital to the proper function of the central nervous system.  
In addition to expression in the central nervous system, subsequent studies have pointed 
to the expression of orexins and orexin receptors in various mammalian peripheral tissues. 
Kirchgessner and Liu (1999) first reported the presence of ORX-A in human intestinal mucosa 
and pancreas. The presence of ORX-A in human plasma is another indicator of widespread 
orexin activity outside of the central nervous system (Arihara et al., 2001; Dalal et al., 2001). 
The distribution of ORX-A in human peripheral tissues was extensively studied by Nakabayashi 
et al. (2003) who showed that immunoreactivity for the peptide was present in several tissues 
that include ganglion cells of the thoracic sympathetic trunk, endocrine cells of the 
gastrointestinal tract, islet cells of the pancreas, and syncytiotrophoblasts and decidual cells of 
the placenta. Additionally, the expression of both orexin receptors (ORXR1 and ORXR2) has 
been identified in adipose tissue (Digby et al., 2006) as well as different areas of the male 
reproductive tract (Karteris et al., 2004) of humans.  
Orexin and orexin receptors have also been detected in a number of peripheral rat and mouse 
tissues. Prepro-orexin mRNA was detected in rat testis (Sakurai et al., 1998) and duodenum 
(Naslund et al., 2002). Johren et al. (2001) investigated the presence of prepro-orexin and orexin 
receptor mRNA in peripheral rat tissues and was able to detect prepro-orexin mRNA in the testis, 
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low levels of ORXR1 mRNA in the kidney, adrenal, thyroid, testis, ovaries and jejunum, plus 
low levels of ORXR2 mRNA in the lung and pituitary. In addition, ORXR1 and ORXR2 mRNA 
have been detected in mouse adipose tissue (Skrzypski et al., 2011), and orexin produced in the 
placenta of mice is believed to be an important contributor to the prenatal development of brown 
adipose tissue (Sellayah et al., 2011). The presence of orexin and orexin receptors in mammalian 
peripheral tissues suggests that the system plays a part in other physiological roles in addition to 
the regulation of feeding behavior and wakefulness (Peyron et al., 1998).  
2.1.3 EFFECTS OF OREXIN IN MAMMALS 
 Orexin has been shown to regulate a variety of processes in mammals. After the initial 
discovery of the peptide, one of the first observations made was that intracerebroventricular 
administration of ORX-A in rats causes an increase in food (Sakurai et al., 1998; Sakurai, 1999) 
and water (Kunii et al., 1999) consumption. Subsequent research by Edwards et al. (1999) 
indicated that ORX-A is a more potent stimulator of food intake than ORX-B in rats. In addition, 
the administration of an orexin receptor antagonist in rats and mice causes a decrease in food 
consumption, providing further evidence of orexin’s stimulatory effect on food intake (Haynes et 
al., 2000, 2002). One of the other central effects of orexin is the control it exerts on sleep and 
wakefulness (Chemelli et al., 1999; Lin et al., 1999; Mignot and Thorsby, 2001). Studies have 
shown that the orexin-producing neurons in the hypothalamus are activated during the awake 
period (Tsujino and Sakurai, 2009). These neurons increase their activity/discharging during 
active waking and stop firing during periods of sleep (Lee et al., 2005; Mileykovskiy et al., 2005; 
Takahashi et al., 2008). In addition, orexin-producing neurons project to the majority of brain 
regions that are involved in regulating wakefulness (see review Alexandre et al., 2013). 
Specifically, cholinergic neurons located in the basal forebrain, whose involvement is also 
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important in regulating sleep and arousal, are directly excited by orexins. Evidence has shown 
that the central injection of ORX-A induces excitation of cholinergic neurons, which in turn 
promotes wakefulness (Eggermann et al., 2001; Xi et al., 2001 Takahashi et al., 2002;). Since 
orexin signaling is involved in controlling feeding behavior and sleep/wake cycles, it is 
inherently involved in control of circadian rhythms in mammals (Mieda et al., 2004; Kantor et 
al., 2009). Neurons located in the suprachiasmatic nucleus (SCN) of the brain serve as the 
control center of the circadian clock. It appears that input from neurons in the SCN to orexin 
neurons exerts regulation over the control of arousal and appetitive states in circadian rhythms 
(Inutsuka and Yamanaka, 2013; Belle et al., 2014). 
 Another central effect of orexin in mammals is the ability to regulate glucose homeostasis 
and energy balance when hypothalamic neurons sense changes in the circulating levels of 
glucose (Tsuneki et al., 2010; 2012). There are several lines of evidence to support the 
relationship between orexin expression and glucose levels. Energy balance in animals has a 
profound input on the orexin system. For example, studies have shown that the extracellular 
presence of glucose and leptin inhibits the excitability of orexin neurons; whereas the presence of 
ghrelin along with decreased glucose and energy levels causes stimulation of orexin neurons 
(Yamanaka et al., 2003; Burdakov et al., 2005). Burdakov et al. (2006) provides further evidence 
of this by showing that the physiological changes in glucose levels that occur between meals is 
reflected in the variations of the firing rate of orexin neurons. Also, the increase in mRNA levels 
of prepro-orexin seen under hypoglycemic conditions supports the idea that orexin is glucose-
responsive (Griffond et al., 1999). The effect of orexin expression in the brain on glucose 
homeostasis and energy balance can be seen in mammals affected with the orexin-deficient 
condition narcolepsy. Humans identified with the condition are known to have decreased energy 
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intake, yet there is an increase in body mass index (BMI), leading to an increase in the 
occurrence of type 2 diabetes (Honda et al., 1986; Schuld et al., 2000). Similarly, transgenic 
mice that were deficient in orexin neurons displayed late-onset obesity even though they 
consumed less food than their non-transgenic counterparts (Hara et al., 2001).  
It has been discovered that orexins are also involved in other physiological processes. A 
number of studies have shown that the orexin system is involved in lipid metabolism. Kukkonen 
(2014) reports that one of the significant ways of signaling for orexin receptors is through lipid 
cascades such as phospholipase C and phospholipase D pathways. In other studies, 
administration of ORX-A, but not ORX-B has the greatest effect on lipid metabolism. ORX-A 
has been shown to decrease levels of lipid peroxidation and apoptosis in rat hypothalamic cells 
(Butterick et al., 2012). ORX-A administration also inhibits lipolysis and stimulates lipogenesis 
in the adipocytes of rats (Skrzypski et al., 2011; Shen et al., 2013) and pigs (Pruszynska-
Oszmalek et al., 2018). Orexins have also been implicated in exerting some control over 
cardiovascular regulation of heart rate and blood pressure in mammals. Central injection of 
orexin in rats causes an increase in sympathetic nerve activity (Shirasaka et al., 1999; Ciriello et 
al., 2003) as well as an increase in heart rate and mean arterial blood pressure (Samson et al., 
1999; Zhang et al., 2005). In addition to changes in sympathetic nerve activity, orexin is also 
involved in the neuroendocrine stress response and the secretion of stress hormones such as 
adrenocorticotropic hormone (ACTH) and corticosterone (Samson et al., 2002, 2007). In mice it 
has been shown that the binding and activation of ORXR2 is more prominent in inducing a stress 
response as opposed to activation of ORXR1 (Yun et al., 2017). Under stress-inducing 
conditions, mobilization of the orexin system causes a stress response that includes associated 
anxiety behavior as well as other endocrine and cardiorespiratory responses (see review Johnson 
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et al., 2012). As a consequence, abnormal function of the orexin system is a factor in psychiatric 
and behavioral disorders. Hyperactivity of the orexin system contributes to anxiety and panic 
disorders, whereas hypoactivity of the system is associated with decreased motivational behavior 
and depression (James et al., 2017). 
2.1.4 EFFECTS OF OREXIN IN MAMMALIAN MITOCHONDRIA 
 In mammals, orexin has been shown to induce differentiation of brown adipose tissue 
(BAT), subsequently leading to thermogenesis (Sellayah et al., 2011; Swami, 2011). One of the 
effects orexin has in this process is the regulation of genes involved in mitochondrial biogenesis. 
The study by Sellayah et al. (2011) revealed several changes in the mitochondrial dynamics of 
mouse preadipocytes treated with ORX-A. The expression of a number of genes involved in 
mitochondrial biogenesis (i.e. PGC-1α, PGC-1β, PPARγ1, and UCP1) were up-regulated 
following treatment. These findings were further supported when subsequent 
immunofluorescence staining revealed an increase in mitochondrial abundance of the treated 
cells. Studies using other cell types treated with ORX-A have also shown effects on 
mitochondrial function. Human neuroblastoma cells treated with ORX-A had increased 
mitochondrial membrane potential (Pasban-Aliabadi, et al., 2017). Additionally, in studies using 
human hepatoma cells (Wan et al., 2017) and human embryonic kidney cells (Sikder and 
Kodadek, 2007), treatment with ORX-A resulted in increased ATP production that shifted from 
glycolysis in the cytoplasm to oxidative phosphorylation in the mitochondria. Taken all together, 
these studies indicate that orexin is able to enhance mitochondrial function, biogenesis, and ATP 
production. 
 
16 
 
2.1.5 OREXIN SYSTEM IN AVIAN SPECIES   
 Significantly fewer studies concerning the orexin system have been conducted in avian 
species when compared to mammals. Chicken prepro-orexin was first cloned, sequenced, and 
characterized by Ohkubo et al (2002). In that study, chicken orexin cDNA was shown to be 
expressed in the periventricular and lateral hypothalamic areas and consisting of 658 bp that 
encode 148 amino acids. Also, chicken ORX-A and ORX-B are evolutionary conserved with 
their mammalian counterparts, showing approximately 85% and 65% similarity at the amino acid 
level (Ohkubo et al., 2002). Characterization of the chicken orexin receptor shows that its cDNA 
has a length of 1869 bp that encode 501 amino acids, which corresponds to mammalian ORXR2  
with an 80% homology (Ohkubo et al., 2003). Studies looking at tissue distribution of orexin and 
orexin receptors in chickens show that the peptides are expressed in the brain (Ohkubo et al., 
2002; Ohkubo et al., 2003; Miranda et al., 2013; Godden et al., 2014), pituitary gland, adrenal 
gland, testis and ovary (Ohkubo et al., 2003), and the stomach and intestine (Arcamone et al., 
2014). 
 Orexin does not appear to elicit the same responses in birds as it does in mammals. One 
of the most noted actions that centrally administered orexin has in mammals is that it stimulates 
feeding/food intake (Sakurai et al., 1998; Edwards et al., 1999; Sakurai, 1999; reviewed by 
Tsujino and Sakurai, 2009). However, central administration of ORX-A or ORX-B did not 
stimulate feed intake in neonatal broiler and layer chicks (Furuse et al., 1999; Katayama et al., 
2010) or adult pigeons (da Silva et al., 2008). Studies examining mRNA expression of prepro-
orexin in the hypothalamus of chicken (Ohkubo et al., 2002) and quail (Phillips-Singh et al., 
2003) following 24h fasting showed no increase in expression, providing further evidence for the 
lack of a stimulatory effect on feeding behavior in birds. The study conducted by Song et al. 
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(2012) did show an increase in prepro-orexin mRNA, but this was measured after 48h fasting, 
which would be an extreme fasting condition for broiler chickens. 
 As stated previously, another hallmark of orexin function in mammals is its effects on the 
regulation of sleep/wakefulness, where a dysfunction in the orexin system is associated with the 
sleep condition narcolepsy (Chemelli et al., 1999). Studies investigating the effects of orexin on 
arousal in birds have been conducted with mixed results. It has been concluded that either 
hypothalamic orexin does not play a role in arousal of the sleep/wake cycle (Miranda et al., 
2013), or that only ORX-A in conjunction with the enzyme monoamine oxidase-A (MAO-A) 
increases arousal in layer chicks only and not broiler chicks (Katayama et al., 2010; Katayama et 
al., 2011). Multiple studies investigating orexin in avian species theorize that the peptide appears 
to be more involved in the regulation of energy balance than feed intake and sleep/wake cycles 
(Miranda et al., 2013; Song et al., 2013; Godden et al., 2014). 
2.2 FEED EFFICIENCY IN POULTRY PRODUCTION 
 Feed efficiency (FE) is one of the most important traits in domestic poultry when 
selecting animals for commercial breeding programs and consumer use. FE is defined as the ratio 
of body weight gained to the amount of feed consumed (gain:feed). Feed conversion ratio (FCR) 
is the inverse of FE (feed:gain) and is the most commonly used term in commercial animal 
production. One of the primary reasons that FE is so important is that feed accounts for up to 
70% of the costs needed to rear an animal to market weight (Willems et al., 2013). Studies 
investigating changes in FE in poultry production have shown that there has been significant 
improvements over the last several decades. The work conducted by Havenstein et al. (1994) is 
one of the hallmark studies illustrating this, where the comparison of broiler strains from 1957 
and 1991 showed that the 1991 strain had a 250 to 300% increase in FE and body weight. A 
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subsequent study showed that 2001 commercial broilers had improved FE when compared to 
1957 broilers regardless of whether they were fed either one of the diets that were representative 
of the two time periods (Havenstein et al., 2003). The increase in growth rates and FE seen over 
the years can be attributed to genetic selection by commercial breeding programs and 
improvements in nutrition and management of nutrition (Havenstein et al., 2007). However, 
despite the improvements seen in growth rate and FE, variations still remain both within and 
between strains of broilers (Emmerson, 1997). Therefore, additional research using modern 
techniques to investigate molecular interactions with genomic and proteomic expression and how 
it affects FE is still needed.  
 In addition to FE and FCR, there are also other methods used to evaluate efficiency in 
commercial animal production. Another common method of evaluating efficiency is a 
measurement termed residual feed intake (RFI). The basic definition of RFI is the difference 
between actual feed intake and predicted feed intake which is based on the regression of 
requirements for production (body weight gain) and the maintenance of body weight (Van Der 
Werf, 2004). The original concept of RFI was introduced by Byerly (1941) and used by Luiting 
(1990) in the production of poultry eggs. Since FE and FCR are ratio-based traits, it is possible 
that while their use selects for larger animals, it can also lead to increased feed costs. On the 
other hand RFI is phenotypically independent of body weight and weight gain and can be used to 
select for animals that have reduced feed intake yet are able to still meet production goals (Bottje 
and Carstens, 2009: Aggrey et al., 2010). A number of alternative methods for measuring 
efficiency have also been reported in recent studies (Willems et al., 2013). These include residual 
maintenance energy (RMEM) which measures energetic efficiency without including feed intake, 
residual gain (RG) that is calculated from linear regression of average daily gain on feed intake 
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and body weight, and residual intake and gain (RIG) which is calculated using both RFI and RG 
(Romero et al., 2009; Berry and Crowley, 2012). 
2.2.1 MITOCHONDRIA, OXIDATIVE STRESS, AND FEED EFFICIENCY IN POULTRY 
 Mitochondria are the major source of cellular energy production and generate about 90% 
of the ATP needed to meet the cell’s demands (Lehninger et al., 1993). In addition to cellular 
energy production, mitochondria are also involved in apoptosis, thermogenesis, and the 
maintenance of calcium homeostasis in the cell (Rossignol et al., 2000). ATP is produced by the 
electron transport chain (ETC) located on the inner mitochondrial membrane. The ETC consists 
of five multi-subunit protein complexes (complex I-V). Electrons from energy substrates move 
down the ETC from complex I to complex IV where they are transferred to oxygen (O2), the 
final electron acceptor. This movement of electrons is coupled to the movement of protons into 
the intermembrane space. The accumulation of protons sets up a proton motive force that drives 
ATP synthesis as the protons are pumped through complex V into the mitochondrial matrix 
(Lehninger et al., 1993).  
 In addition to its involvement in ATP production, the ETC is a major source of reactive 
oxygen species (ROS) production and endogenous oxidative stress (Yu, 1994). ROS include 
compounds such as superoxide, hydrogen peroxide, and hydroxyl radicals. ROS are formed in 
the mitochondria due to electrons leaking from the ETC before they are able to reach the 
terminal electron acceptor (O2). Instead of being completely reduced to water, 2 to 4% of the O2 
used by mitochondria may only be partially reduced to superoxide (Boveris and Chance, 1973; 
Chance et al., 1979). Complex I and complex III are considered to be the primary producers of 
superoxide within the ETC (Chen et al., 2003; Drose and Brandt, 2012). Superoxide is typically 
converted to the less reactive hydrogen peroxide by the enzyme superoxide dismutase. However, 
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when hydrogen peroxide is in the presence of iron (Fe2+) and copper (Cu2+) it can be converted 
into highly reactive hydroxyl radicals. The accumulation of ROS can lead to the oxidative 
damage of DNA, lipids, and proteins that exacerbate inefficiencies in the mitochondria, thus 
initiating a continuous cycle of cellular damage and ROS production.  
 Several studies have been conducted to investigate the relationship between 
mitochondrial function and feed efficiency in broilers. Bottje et al. (2002) was the first study to 
show that in the comparison of breast muscle isolated from broilers with low FE and high FE, the 
low FE broilers had impaired mitochondrial function. The impaired function was observed in the 
form of lower respiratory chain coupling that was possibly due to decreased activity of 
Complexes I and II in the ETC, greater electron leak from the ETC, and increased hydrogen 
peroxide production. This study was significant because the broilers came from the same genetic 
line and were fed the same diet. Additional studies by Iqbal et al. (2004, 2005) indicated that 
ETC complex activities were significantly lower in muscle and liver mitochondria of low FE 
broilers. In a subsequent study by the same group, mitochondria were isolated from the 
duodenum of broilers phenotyped for low and high FE and similar to the observations in breast 
muscle, the production of oxygen radicals was higher in low FE mitochondria (Ojano-Dirain et 
al., 2004). Since increased levels of hydrogen peroxide were consistently observed in 
mitochondria from low FE broilers, it would be logical to hypothesize that oxidation of proteins 
would also be higher. One method to determine the presence of protein oxidation is to quantify 
the levels of protein carbonyls, which serve as an indicator (Stadtman and Levine, 2000). In a 
number of studies, breast muscle mitochondria as well as homogenate from gut, leg, heart, liver, 
and lymphocytes of low FE broilers displayed increased amounts of protein carbonyls when 
compared to high FE broilers, further supporting the evidence that the mitochondria and tissue of 
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low FE birds are more susceptible to protein oxidation/damage (Iqbal et al., 2004, 2005; Ojano-
Dirain et al., 2005, 2007; Lassiter et al., 2006; Tinsley et al., 2010). 
 Despite the oxidative damage that is caused by high levels of ROS, low levels of these 
molecules are actually important in signal transduction and control various physiological 
processes (e.g. growth factor signaling, mitochondrial biogenesis, insulin sensitivity) that affect 
cell growth and proliferation (see review Finkel, 2011). The mitochondria in particular are 
thought to play a role in the control of these processes through redox signaling, since they 
possess both a system for generating ROS and for antioxidant protection (Chandel, 2010; Finkel, 
2012). As mentioned earlier, the generation of superoxide occurs primarily in complex I and 
complex III. It is believed that the superoxide produced by complex I is released into the 
mitochondrial matrix where ROS are the most damaging since they can easily react with 
mitochondrial DNA and other molecules easily affected by oxidative damage; whereas ROS 
generated via complex III is released into the intermembrane space where it is converted into 
hydrogen peroxide that diffuses into the cytosol where it can act as a second messenger in 
cellular signaling (Bleier and Rose, 2013; Bleier et al., 2015). Since ROS can function in signal 
transduction and secondary messaging, it is possible that the low FE phenotype broilers, 
characterized by increased ROS levels, may show differences in gene and protein expression of 
key molecules when compared to the high FE phenotype. 
2.2.2 GENOMIC AND PROTEOMIC EXPRESSION ANALYSIS OF FEED EFFICIENCY IN 
POULTRY 
 Since the previously cited studies have shown that low FE broilers are more susceptible 
to elevated levels of ROS production and oxidative stress due to defects in mitochondrial 
function, and that changes in the levels of ROS can have an impact on genomic and proteomic 
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expression, global expression studies have also been conducted to determine which genes and 
proteins are affected in order to develop a comprehensive understanding of the cellular basis of 
FE. Analysis of global gene (Kong et al., 2011; Bottje et al., 2012; Zhou et al., 2015) and protein 
(Kong et al., 2016) expression was conducted on breast muscle acquired from high and low FE 
broilers. The online software program Ingenuity Pathway Analysis (IPA; 
http://apps.ingenuity.com) was used in these studies to interpret the data and generate predictions 
that provide a visualization of the networks of genes and proteins that are associated with FE. In 
the initial microarray analysis of gene expression, the findings from Kong et al. (2011) and 
Bottje et al. (2012) indicated that the high FE phenotype is derived from the upregulation of 
genes associated with growth-promoting anabolic processes, signal transduction pathways, and 
enhanced energy sensing and energy production; whereas genes upregulated in the low FE 
phenotype were associated with muscle fiber development and function, organization of 
cytoskeletal architecture, fatty acid oxidation, growth factors, and genes induced in response to 
oxidative stress. Subsequent analysis of genomic data obtained from the same group of high and 
low FE broilers also indicated that a number of genes involved in insulin signaling (i.e. AMPK, 
PI3K, PDK1, S6K, mTORC1) were predicted to be upregulated in the high FE phenotype (Bottje 
et al., 2014). In the same study, myostatin, which is a well-known inhibitor of muscle growth and 
development (McPherron et al., 1997; Kollias and McDermott, 2008) was predicted to be 
upregulated in the low FE phenotype. Interestingly, progesterone signaling within avian 
mitochondria also appears to be associated with the divergence seen in the broiler FE phenotype 
(Bottje et al., 2017). 
 Shotgun proteomic analysis conducted on the high and low FE phenotype breast muscle 
samples by Kong et al. (2016) revealed some interesting results. A number of mitochondrial 
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proteins were identified as being upregulated in the high FE phenotype, indicating that 
mitochondrial expression was greater in this group. Also, based on the differential expression of 
proteins it was predicted that molecules involved in hormone signaling (i.e. insulin receptor, 
insulin like growth receptor 1, progesterone, triiodothyronine) would be activated in the high FE 
phenotype. Subsequent analysis of the dataset revealed that a mitochondrial isoform of creatine 
kinase as well as proteins involved in energy production and transfer (i.e. ANT, VDAC, ETC 
proteins) were upregulated in the high FE phenotype (Bottje et al., 2017a). Furthermore, it was 
revealed that the enrichment of mitochondrial ribosomal proteins and proteins involved in 
ribosomal assembly were enhanced in the high FE phenotype (Bottje et al., 2017b). The 
collective results obtained from the proteomic analysis of breast muscle from the high and low 
FE phenotype suggests that the high FE phenotype is characterized by enhanced mitochondrial 
expression in breast muscle, an enhanced ability to maintain the energy requirements needed in 
skeletal muscle mitochondria, and enhanced translation of proteins. 
2.3 MYOSTATIN AND INSULIN SIGNALING IN MUSCLE GROWTH AND 
DEVELOPMENT 
 Myostatin (MSTN), initially referred to as growth/differentiation factor-8 (GDF-8), is an 
inhibitor of muscle growth and development that was first reported by McPherron et al. (1997) 
where myostatin-null mice showed an increase in muscle mass due to both hyperplasia and 
hypertrophy of muscle fibers. Myostatin is a member of the transforming growth factor-β (TGF-
β) superfamily. TGF-β members are involved in growth and differentiation and play an 
important role in regulating development in embryos, and maintenance of tissue homeostasis in 
adult animals (McPherron and Lee, 1996). In mice, the myostatin protein was characterized as 
being 376 amino acids in length and containing a signal sequence for secretion, a proteolytic 
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processing site, and a carboxy-terminal region of conserved cysteine residues, which is 
characteristic of TGF-β proteins (McPherron et al., 1997). In the same article it was also reported 
that myostatin is highly conserved across species, including mammals as well as chickens.  
Myostatin’s role as a negative regulator of muscle growth has been illustrated in a 
number of species, including cattle, humans, sheep, and dogs, where mutations in the myostatin 
gene that lead to a loss of function have resulted in a significant increase of muscle mass 
(Kambadur et al., 1997; Schuelke et al., 2004; Clop et al., 2006; Mosher et al., 2007). It has been 
shown that myostatin’s negative effect on muscle growth is caused by its ability to prevent the 
proliferation and differentiation of myoblasts into myotubes (Thomas et al., 2000). The 
mechanism by which this happens appears to be dependent on more than one signaling pathway 
in the cell. A good illustration of initial myostatin signaling is provided by Lee and Glass (2011). 
Myostatin first binds to either one of two activin type-II receptors (ActRIIA, ActRIIB), and 
subsequently one of the two type-I receptors (ALK4, ALK5) which leads to 
phosphorylation/activation of one or both of the transcription factors SMAD2 and SMAD3. The 
activation of SMAD2, SMAD3 ultimately leads to the blockage of the transcription factor 
MyoD, thereby inhibiting differentiation and proliferation of myoblasts (Zhu et al., 2004; Allen 
and Unterman, 2007). Inhibition of this signaling pathway occurs when myostatin binds to either 
the protein follistatin (FSTN) or the soluble form of the ActRIIB receptor (ActRIIB-Fc) instead 
of the true membrane-bound receptors (Lee and McPherron, 2001; Lee and Glass, 2011).   
The regulation of muscle growth by myostatin is also linked to components of the insulin 
signaling pathway, where it is intricately involved in signaling via the protein kinase Akt (see 
reviews Elkina et al., 2011; Elliott et al., 2012). Akt is able to influence either protein synthesis 
or protein degradation through multiple routes during insulin signaling that can be affected by 
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the expression of myostatin. Typically, Akt promotes myoblast differentiation and myotube 
hypertrophy through the subsequent activation of mTOR and p70s6K. However, signaling by 
myostatin through Akt can activate the transcription factor Forkhead box O (FoxO), which leads 
to an increase in expression of the proteasome ubiquitin ligase atrogin-1 that induces protein 
degradation and the loss of muscle mass. The regulation of muscle growth and development 
through signal transduction involving myostatin and the insulin pathway is complex since it 
involves multiple pathways and is not yet fully understood, particularly in avian species.  
2.4 MECHANISMS OF HORMONE ACTIONS IN MAMMALIAN MITOCHONDRIA 
 Steroid and thyroid hormones influence a number cellular processes in mammals such as 
growth, development, and metabolism. Once a hormone binds to its respective receptor it 
functions as a transcription factor whose influence on the activation or repression of certain 
genes is mediated by hormone response elements (HREs). HREs are short DNA sequences 
typically located in the promoter region of genes, where binding of the hormone/receptor 
complex to the HRE initiates activation of the gene (Wu et al., 2001; Scheller and Sekeris, 2003). 
In addition to the classical activation of nuclear-encoded genes, evidence also indicates that 
hormones may act on mitochondria as well by 2 mechanisms, either an indirect or a direct 
mechanism. In the indirect mechanism, once a hormone binds to its respective receptor, it is 
translocated to the nucleus where binding to HREs leads to the activation of nuclear-encoded 
mitochondrial transcription factors (e.g. peroxisome proliferator-activated receptor gamma 
coactivator 1-alpha (PGC-1α); mitochondrial transcription factor A (mtTFA)), and nuclear-
encoded mitochondrial proteins of the electron transport chain (see reviews by Wrutniak-Cabello 
et al., 2001; Chen et al., 2005; Psarra et al., 2006). The activation of these nuclear-encoded genes 
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that function in the mitochondria exerts a positive effect on mitochondrial biogenesis, as well as 
metabolism, growth, and development.  
In the direct mechanism, instead of initially signaling through the nucleus, hormones bind 
directly to receptors located on or within the mitochondria. Studies show that mammalian 
mitochondria contain receptors for progesterone (Dai et al., 2013; Feng et al., 2014), 
glucocorticoid (Demonakos et al., 1993; Moutsatsou et al., 2001; Du et al., 2009), thyroid 
(Wrutniak et al., 1995; Wrutniak-Cabello et al., 2001), and estrogen (Chen et al., 2004a,b). The 
hormone/receptor complex then binds to mitochondrial DNA (mtDNA), where it has been shown 
that mtDNA also contains HREs similar to their nuclear counterparts. HREs located within 
mtDNA have been identified for steroid hormones such as estrogen, progesterone, and 
glucocorticoids, as well as thyroid hormones (Demonakos et al., 1995; reviewed by Chen et al., 
2005 and Psarra et al., 2006). Since mtDNA encodes for a number of the protein subunits located 
in the electron transport chain, the presence of hormone receptors and HREs within the 
mitochondrial genome provides another avenue for the translation of mitochondrial-encoded 
proteins, thereby enhancing energy production and mitochondrial function. 
2.4.1 EFFECTS OF HORMONES ON MAMMALIAN MITOCHONDRIAL FUNCTION 
 Studies have been conducted in various mammalian tissue types to further understand the 
effects that hormone/receptor signaling have on mitochondrial physiology. For instance, 
progesterone signaling is typically associated with the reproductive process in females, however 
research has shown that the hormone and its receptor is influential in the function of 
mitochondria. A truncated progesterone receptor localized to the outer mitochondrial membrane 
was first recognized by Dai et al. (2013) in human heart tissue. In the same study, expression of 
this mitochondrial receptor was accompanied by an increase in cellular respiration (increased 
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membrane potential and O2 consumption). A similar study using human uterine cells also 
showed an increase in mitochondrial membrane potential following treatment with progestin 
(Feng et al., 2014). Also, mitochondria isolated from rat brain and treated with progesterone and 
estrogen showed enhanced respiratory function and reduced oxidative damage (Irwin et al., 
2008). The estrogen receptor is also known to be localized to the mitochondria in human and rat 
tissues (Yang et al., 2004) and is beneficial to mitochondria through the modulation of 
mitochondrial metabolism and gene expression (Liao et al., 2015; Chmielewska et al., 2017).       
Overall these studies indicate that the actions of progesterone and estrogen signaling positively 
affect mitochondrial function. 
 Glucocorticoid receptors have been identified in mammalian mitochondria using 
immunoblotting, immunofluorescence, and immunogold electron microscopy (Demonakos et al., 
1993; Scheller et al., 2000). The receptor is normally located in the cytoplasm and upon binding 
with the hormone is translocated to the mitochondria (Scheller et al., 2002). Translocation of the 
receptor to the mitochondria is chaperoned by heat shock proteins and Bcl-2-associated 
athanogene (Bag-1) (Du et al., 2009). This association of glucocorticoid receptors with Bcl-2 
proteins plays a role in regulating apoptosis in the mitochondria (Prenek et al., 2017). Reports 
have also illustrated how glucocorticoid receptors present in the mitochondria affect energy 
production and activity. Application of the synthetic glucocorticoid dexamethasone stimulated 
mitochondrial biogenesis in rat skeletal muscle and cultures of C2C12 cells (Weber et al., 2002). 
Transfected HepG2 that overexpress mitochondrial-targeted glucocorticoid receptors showed an 
increase in mitochondrial ATP production, RNA synthesis, and expression of the electron 
transport chain protein cytochrome oxidase subunit I (Psarra and Sekeris, 2011). There has even 
been evidence presented that the presence of a mitochondria-specific isoform of the 
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glucocorticoid receptor causes an increase in mitochondrial mass, oxygen consumption, and ATP 
production (Morgan et al., 2016). 
 Thyroid hormones are an important component in normal growth, development, and the 
regulation of metabolism (Yen, 2001). Similar to steroid hormone receptors, thyroid hormone 
receptors function as ligand-activated transcription factors by interacting with DNA-binding sites 
that regulate gene and protein expression (Psarra et al., 2006). It has been discovered that 
mammalian mitochondria contain two mitochondria-specific isoforms of the thyroid alpha 
receptor. These two truncated thyroid receptor alpha isoforms (p28 and p43) have been shown to 
increase mitochondrial gene expression, oxidative phosphorylation, thermogenesis (Bassett et al., 
2003), and influence cell differentiation and apoptosis (Wrutniak-Cabello et al., 2017). The p43 
isoform, which is located in the mitochondrial matrix and has direct contact with the HREs of the 
mitochondrial DNA appears to be the primary effector on mitochondrial function (Wrutniak et 
al., 1995). 
 Currently, there is no scientific literature published indicating that the insulin receptor is 
present in mammalian mitochondria. However reports do show that insulin signaling affects 
mitochondrial function. Studies in human neuronal cells show that the binding of insulin to its 
receptor induces the production of ROS, specifically H2O2, by mitochondria (Pomytkin, 2012). 
This H2O2 is generated primarily by the oxidation of succinate at complex II within the ETC and 
leads to the autophosphorylation and subsequent activation of the insulin receptor. The 
subsequent phosphorylation cascade within the insulin signaling pathway affects cellular 
mechanisms that help to regulate proliferation, metabolism, and differentiation in the cell. 
Additionally, studies in human skeletal muscle have shown that the infusion of insulin increases 
mitochondrial protein expression, ETC activity, and mitochondrial ATP synthesis (Stump et al., 
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2003; Asmann et al., 2006). Recent reports have shown that multiple members of the family of 
receptor tyrosine kinases (RTKs) translocate to the mitochondria where they phosphorylate 
mitochondrial proteins and regulate mitochondrial bioenergetics (Ding et al., 2012; Salvi et al., 
2013). The insulin receptor is a RTK and it is possible that it may translocate to the 
mitochondria, but to date has not been identified as such. 
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3.1 ABSTRACT 
Orexin A and B, orexigenic peptides produced primarily by the lateral hypothalamus that 
signal through two G-proteins coupled receptors, orexin receptors 1/2, have been implicated in the 
regulation of several physiological processes in mammals. In avian (non-mammalian vertebrates) 
species, however, the physiological roles of orexin are not well defined. Here we provide novel 
evidence that not only is orexin and its related receptors 1/2 (ORXR1/2) expressed in chicken 
muscle tissue and quail muscle (QM7) cell line, orexin appears to be a secretory protein in QM7 
cells. In vitro administration of recombinant orexin A and B (rORX-A and B) differentially 
regulated prepro-orexin expression in a dose-dependent manner with up-regulation for rORX-A 
(P<0.05) and down-regulation for rORX-B (P<0.05) in QM7 cells. While both peptides up-
regulated ORXR1 expression, only high dose of rORX-B decreased the expression of ORXR2 
(P<0.05). The presence of orexin and its related receptors and the regulation of its own system in 
avian muscle cells indicate that orexin may have autocrine, paracrine and/or endocrine roles. 
rORXs differentially regulated mitochondrial dynamics network. While rORX-A significantly 
induced the expression of mitochondrial fission-related genes (DNM1, MTFP1, MTFR1), rORX-
B increased the expression of mitofusin2, OPA1 and OMA1 genes that are involved in 
mitochondrial fusion. Concomitant with these changes, rORXs differentially regulated the 
expression of several mitochondrial metabolic genes (av-UCP, av-ANT, Ski and NRF-1) and their 
related transcriptional regulators (PPARγ, PPARα, PGC-1α, PGC-1β and FoxO-1) without 
affecting ATP synthesis. Taken together, our data represent the first evidence of the presence and 
secretion of orexin system in the muscle of non-mammalian species and its role in mitochondrial 
fusion and fission, probably through mitochondrial-related genes and their related transcription 
factors. 
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3.2 INTRODUCTION 
 Orexins (ORX-A and ORX-B) (56), also referred to as hypocretin 1 and 2 (21), are two 
peptides proteolytically derived from a single precursor (prepro-orexin) produced mainly in the 
dorsal and lateral hypothalamic areas and perifornical nucleus in rat and humans (21, 56). 
Prepro-orexin mRNA was detected also in rat testis (56) and duodenum (47). Recently, 
immunoreactivity for ORX-A was detected in several human peripheral tissues including 
ganglion cells of the thoracic sympathetic trunk, endocrine cells of the gastrointestinal tract, 
islets cells of the pancreas and syncytiotrophoblasts and decidual cells of the placenta (46). 
 Orexins signal through two ubiquitously expressed G-proteins coupled receptors: orexin 
receptor 1 (ORXR1) and orexin receptor 2 (ORXR2) (8, 25, 31, 35, 42, 56) and regulate several 
physiological processes in mammals. Consistent with this, central administration of orexins 
increases food and water intake in mammals (55). Other central effects of orexins include control 
of wakefulness (14, 41, 44), circadian clock (6), energy and glucose homeostasis (71-73), lipid 
metabolism (62, 63), heart rate and blood pressure (19, 78), and neuroendocrine response to 
stress (57) have been reported. As orexins and its receptors are not restricted to the 
hypothalamus, these aforementioned pleiotropic actions of orexins might be also mediated 
through a direct interaction with peripheral target tissues (20, 26, 31). 
 In contrast to mammals, little is known about orexin system distribution and functions in 
avian (non-mammalian vertebrates) species and such studies are very limited. Ohkubo et al. (48) 
were the first to clone the chicken prepro-orexin, which is highly conserved among vertebrates 
and found that it was expressed in periventricular and lateral hypothalamic areas. In a subsequent 
study, the same group characterized the chicken orexin receptor and found that it corresponded 
to the type 2 mammalian orexin receptor (49). Both orexin and its receptor were expressed in 
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chicken brain and gonads (testis and ovary) (49). Central administration of orexin did not affect 
feed intake in neonatal chickens (24) and its effects on sleep/wakefulness cycle is still 
controversial (33, 34, 45). The localization of orexin and its receptors in chicken peripheral 
tissues such as testis, ovary, stomach, and intestine (3, 49), indicate that orexin system may have 
other physiological functions rather than the regulation of feeding behavior. 
 Orexin has been recently shown to regulate mitochondrial biogenesis and induce brown 
adipose tissue (BAT) differentiation and thermogenesis in mammals (61, 66). Mitochondria are 
dynamic organelles that constantly fuse and divide, and an imbalance of these two processes 
dramatically alters mitochondrial morphology and function (15). The molecular mechanism that 
controls mitochondrial dynamics and biogenesis is a complex network requiring the participation 
and coordination of the nuclear and mitochondrial genomes. This network has been partially 
unraveled in mammals after the identification of some of the genes responsible for mitochondrial 
fusion [mitofusins (MFN1 and MFN2), and optic atrophy 1 (OPA1)], fission [dyanamin-related 
protein 1 (Drp1 or DNM1), fission 1 (FIS1), and mitochondrial protein 18 kDa], and biogenesis 
[peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and nuclear 
respiratory factor 1 (NRF1)]. Such mitochondrial network and its integration are still unknown in 
avian species.  
 As chickens do not have functional BAT, we undertook the present study to investigate 
whether orexin system is expressed in the avian muscle, the main site for thermogenesis, and its 
potential role in the regulation of muscle mitochondrial dynamics, biogenesis and function. 
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3.3 MATERIALS AND METHODS 
3.3.1 ANIMALS 
 One-day-old male and female Cobb-500 broiler chickens were reared on floor pen in 
controlled environment room with ad libitum access to food (12.6 MJ kg-1, 22% protein) and 
clean water until 3 weeks of age. The ambient temperature was reduced gradually from 32 to 
26°C at 21 days of age and the relative humidity was 55 ± 5%. Birds (n=4 for each gender) were 
killed by cervical dislocation, and leg muscles, whole brain, hypothalamus, liver, ovary and testis 
were quickly removed and snap frozen in liquid nitrogen and stored at -80°C until use. Animal 
care and housing and all procedures were approved by the University of Arkansas Animal Care 
and Use Committee under protocol (no. 13039). 
3.3.2 QUAIL MUSCLE (QM7) CELL CULTURE AND TREATMENTS 
 QM7 cells were grown in M199 medium (Life technologies, grand Island, NY) 
complemented with 10% FBS (Life technologies, grand Island, NY), 10% tryptose phosphate 
(Sigma-Aldrich, St. Louis, MO) and 1% penicillin-streptomycin (Biobasic, Amherst, NY) at 
37°C under a humidified atmosphere of 5% CO2 and 95% air. At 80-90% confluence, cells were 
synchronized overnight in serum free medium and treated with human recombinant orexin A or 
B (0, 10 and 100 nM) (Interchim, Montlucon, France) for 24h. Untreated cells were used as 
control. The dose and duration of treatments were chosen based on pilot and previous published 
experiments (12, 62, 63). QM7 cells were washed twice with phosphate buffered saline (PBS 
1X) and incubated for 12h in medium with brefeldin A (0.3 µg/mL) and lysates and medium 
were subjected to immunoblot analysis. 
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3.3.3 RNA ISOLATION AND QUANTITATIVE REAL-TIME PCR 
 Nuclear, cytoplasmic, and total RNA were isolated, as previously described (30), with 
some modifications. Briefly, cells were rinsed twice and harvested in 5 ml of ice-cold PBS and 
centrifuged [1,000 relative centrifugal force (RCF), 4°C, 5 min]. Cells were resuspended in lysis 
buffer A [10 mM Tris (pH 8.0), 140 mM NaCl, 1.5 mM MgCl2, 0.5% NP-40, 2 mM vanadyl 
ribonucleoside complex (VRC; Sigma-Aldrich)] and incubated on ice for 5 min. One-fifth of the 
lysate was used for total RNA isolation. The rest was centrifuged (1,000 RCF, 4°C, 3 min) to 
pellet the nuclei. The nuclear pellet was washed twice and then resuspended in the lysis buffer A. 
All RNA fractions (total, cytoplasmic, and nuclear) were extracted by TriZOL reagent (Life 
Technologies) according to the manufacturer’s recommendations, DNase-treated, and reverse-
transcribed (Quanta Biosciences, Gaithersburg, MD). RNA integrity and quality were assessed 
using 1% agarose gel electrophoresis, and RNA concentrations and purity were determined for 
each sample by Take 3 microvolume plate using Synergy HT multimode microplate reader 
(BioTek, Winooski, VT). The RT products (cDNAs) were amplified by real-time quantitative 
PCR (Applied Biosystems, 7500 real-time PCR system) with Power SYBR Green Master Mix. 
Oligonucleotide primers used for chicken prepro-orexin (ORX), ORXR1, ORXR2, uncoupling 
protein (av-UCP), adenosine nucleotide translocator 1(ANT1), the nuclear sarcoma viral 
oncogene homolog (Ski), NRF-1, peroxisome proliferator-activated receptor alpha and gamma 
(PPARα and PPARγ), forkhead box protein O1 (FoxO-1), peroxisome proliferator-activated 
receptor gamma coactivator 1α and β (PGC-1α and PGC-1β), OxPhos Complex IV subunit I, 
Cox 5a, mitochondrial single-stranded DNA binding protein 1 (mtSSBP1), mitochondrial 
transcription factor A (TFAM), MFN1 and MFN2, dynamin-related protein 1 (DNM1 or Drp1), 
OPA1, OMA1 zinc metallopeptidase (OMA1), mitochondrial fission process 1 (MTFP1), 
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mitochondrial fission regulator 1 (MTFR1), mitochondrial fission factor 1, and the housekeeping 
gene ribosomal 18S are summarized in Table 1. The quantitative PCR (qPCR) cycling conditions 
were 50°C for 2 min, 95°C for 10 min followed by 40 cycles of a two-step amplification 
program (95°C for 15 s and 58°C for 1 min). At the end of the amplification, melting curve 
analysis was applied using the dissociation protocol from the Sequence Detection system to 
exclude contamination with unspecific PCR products. The PCR products were also confirmed by 
agarose gel and showed only one specific band of the predicted size. For negative controls, no 
RT products were used as templates in the qPCR and verified by the absence of gel-detected 
bands. Relative expressions of target genes were determined by the 2-ΔΔCt method (60). 
3.3.4 REVERSE TRANSCRIPTION AND CONVENTIONAL PCR 
 Total RNA was reverse transcribed as described in the previous section. Long fragments 
of ORX (411 bp), ORXR1 (832 bp), and 18S (515 bp) were amplified by PCR using 
oligonucleotide primers specific for chicken ORX, ORXR1, and 18S (Table 1). PCR was 
performed in 50 µl containing 5 µl of the RT reaction, 1 µl of forward and reverse primer, and 43 
µl of platinium PCR SuperMix (Life Technologies). Thermal cycling parameters were as 
follows: 1 cycle of 94°C for 4 min, followed by 39 cycles of 94°C for 30 s, 50–55°C for 30 s, 
72°C for 1 min, with a final extension at 72°C for 10 min. The amplified fragments were 
separated on a low-melting point agarose gel (1%), and the appropriate bands were cut out, 
purified by using spin-column DNA gel extraction kit (Biobasic, Amherst, NY), and stored at 
-20°C. 
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3.3.5 NORTHERN BLOT ANALYSIS 
 For probe preparation, the long PCR fragments (obtained as described above) were 
cloned using the TOPO PCR cloning kit (Life Technologies) and automatically sequenced using 
an Applied Biosystems automated sequencer. Then 100 ng of cloned probes were labeled with 
biotin using North2South Biotin Random Prime Labeling kit, according to manufacturer 
recommendations (Pierce Thermo Scientific, Rockford, IL). As previously described (32), total 
RNA (10 µg) was separated by size on 1% agarose, 0.7 M formaldehyde gels and visualized on 
an ultraviolet transilluminator to ensure consistent loading between different groups and to 
record the distance of migration of the 18S and 28S rRNA bands. RNA ladder (0.1–10 kb; Life 
Technologies) was used as markers. Gels were then transferred to a positively charged Nylon 
membrane (Hybond-N+, GE Healthcare Bio-Sciences, Buckinghamshire, UK) by a vacuum 
blotting apparatus (VacuGene XL Vacuum Blotting System, GE Healthcare Bio-Sciences). The 
RNAs were crosslinked to the membranes by ultraviolet irradiation and baked at 80°C for 20–30 
min. Membranes were hybridized with biotin-labeled DNA probes (prepro-orexin or 18S) at 
42°C overnight. On the following day, the membranes were rinsed twice with 1X SSC, 0.1% 
SDS at 55°C. Each wash was for 20 min, and then the signals were detected by using the 
chemiluminescent nucleic acid detection kit (Pierce Thermo Scientific, Rockford, IL) and the 
FluorChem M MultiFluor System (Proteinsimple, Santa Clara, CA). 
3.3.6 WESTERN BLOT ANALYSIS 
 Muscle tissues and QM7 cells were homogenized in lysis buffer (10 mM Tris base, pH 
7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% Triton X-100, 0.5% NP-40, protease, and 
phosphatase inhibitor cocktail). Protein concentrations were determined using Synergy HT 
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multimode microplate reader (BioTek, Winooski, VT) and a Bradford assay kit (Bio-Rad, 
Hercules, CA) with BSA as a standard. Proteins (70 µg) were run on 4–12% Novex 
Bis-Tris gels (Life Technologies). The transferred membranes were blocked for 1 h at room 
temperature, and incubated with primary antibodies (diluted 1:500 –1:1,000) at 4°C overnight. 
The polyclonal antibodies used were as follows: rabbit anti-mouse ORX, rabbit anti-rat ORXR1 
and ORXR2, rabbit anti-ANT1, rabbit anti-PGC-1α, rabbit anti-MFN1, rabbit anti-MFN2, and 
rabbit anti-OPA1. Protein loading was assessed by immunobloting using rabbit anti-β actin or 
rabbit anti-vinculin. Prestained molecular weight marker (precision plus protein Dual color) was 
used as a standard (Bio-Rad, Hercules, CA). All of the primary antibodies were purchased from 
(Interchim, Montlucon, France) except for anti-β actin from Cell Signaling Technology 
(Danvers, MA), anti-vinculin from Sigma-Aldrich and anti-ANT1 from Pierce Thermo Scientific 
(Rockford, IL). Anti-PGC-1α, anti-MFN1, anti-MFN2, and anti-OPA1 were from Dr. Nicholas 
Greene (University of Arkansas). The secondary antibodies were used (1:5,000) for 1 h at room 
temperature. The signal was visualized by enhanced chemiluminescence (ECL plus) (GE 
Healthcare Bio-Sciences) and captured by FluorChem M MultiFluor System (Proteinsimple). 
Image acquisition and analysis were performed by AlphaView software (version 3.4.0, 1993–
2011; Proteinsimple). 
3.3.7 IMMUNOFLUORESCENCE 
 Immunofluorescence was performed as previously described (23). Briefly, cells were 
grown to 50–60% confluence in chamber slides (Lab-Tek, Hatfield, PA) and fixed in methanol 
for 10 min at -20°C. Cells were blocked with protein block serum-free blocking buffer (Dako, 
Carpinteria, CA), and incubated with rabbit anti-ORX, anti-ORXR1, or anti-ORXR2 antibody 
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(1:200; Interchim, Montlucon France) overnight at 4°C and visualized with Alexa Fluor 488-
conjugated secondary antibody (Molecular Probes, Life Technologies). After DAPI 
counterstaining, slides were cover-slipped in Vectashield (Vector Laboratories, Burlingame, 
CA). Images were obtained using the Zeiss Imager M2 with a 20X Plan-APOCHROMAT 
20X/0.8 objective and a 100X EC PLANNEOFLUOR 100X/1.3 oil objective. The Alexa Fluor 
488 fluorophore was observed through filter set 38 1031–346 with an excitation of BP 470/40, 
beamsplitter of FT 495, and emission spectrum of BP 525/50. Differential interference contrast 
images were collected using DIC M27 condensers. The Alexa Fluor 488 fluorophore was excited 
for 500 ms prior to capturing each image using an Axio Cam MR3 camera. All analysis was 
performed using AxioVision SE64 4.9.1 SP1 software (Carl Zeiss Microscopy 2006–2013). 
3.3.8 ANALYSIS OF CELLULAR BIOENERGETICS 
 Analysis of cellular bioenergetics was conducted using the XF24 extracellular Flux 
Analyzer (Seahorse Biosciences, North Billerica, MA). Cells were plated into each well of a 24-
well Seahorse cell culture plate and allowed to attach. Once the cells were attached, the growth 
media listed in the previous section were exchanged for fasting (no FBS) media for overnight 
incubation. Cells were treated then with rORX-A or rORX-B (10 and 100 nM, Interchim, 
Montlucon, France) for 24 h. Untreated cells were used as a control. The following day, the cell 
culture media were changed to XF Assay Media (unbuffered DMEM containing 25 mM glucose 
and 10 mM sodium pyruvate; Seahorse Biosciences, North Billerica, MA) for the XF 
bioenergetics analysis. Cellular bioenergetics analysis was conducted by first measuring the 
baseline oxygen consumption rate (OCR), followed by measuring the OCR after sequential 
addition of chemical mitochondrial effectors; oligomycin (inhibitor of ATP synthesis by 
blocking the proton channel of the F0 portion ATP synthase, complex V), carbonyl cyanide-p-
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trifluoromethoxyphenylhydrazone, FCCP (uncoupler,), and antimycin A (blocker of O2 
consumption and inhibitor of complex III). All three chemicals were purchased from Sigma-
Aldrich (St. Louis, MO). Pilot studies were conducted to optimize QM7 cell seeding density (25 
X 103 cells/well) and concentrations of oligomycin (1.5 µM), FCCP (250 nM), and antimycin A 
(10 µM) prior to assessing bioenergetics response to orexin treatments. Nonmitochondrial OCR 
values for each well were subtracted from basal OCR, OCR following oligomycin, and OCR 
following FCCP in the same well and bioenergetics components, including oxygen consumption 
due to ATP synthesis, mitochondrial oxygen reserve capacity, and proton leak were determined, 
as previously described (28, 39). 
3.3.9 MITOCHONDRIAL BIOGENESIS AND DNA QUANTITATION 
 After orexin treatments for 24 h, mitochondrial content of QM7 cells was determined by 
measuring mitochondrial DNA levels and mitochondrial mass with MitoTracker Red CMXRos 
(Life Technologies). Mito-Tracker Red CMXRos is a cell-permeable mitochondrion-selective 
dye that has been used for mitochondrial mass measurement (61). QM7 cells were washed twice 
with PBS and stained with 75 nM MitoTracker Red CMXRos for 15 min at 37°C, and 
fluorescence intensity was detected following the protocol provided by the manufacturer. 
DNA was extracted using the EZ-10 spin column genomic DNA kit (Biobasic, Amherst, NY), 
and the expression of the chicken mtDNA was measured by real-time qPCR in the presence of 
the oligonucleotide primers summarized in Table 1. The qPCR conditions and parameters are 
described above. 
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3.3.10 STATISTICAL ANALYSES 
 Data were analyzed by one-factor ANOVA. Significant differences among individual 
group means were determined with Student-Newman-Keuls (SNK)’s multiple range test using 
the GraphPad Prism version 6.00 for Windows, GraphPad Software (La Jolla, CA). Significance 
was set at P < 0.05. Data are expressed as the means ± SE. 
3.4 RESULTS 
3.4.1 BOTH OREXIN AND ITS RELATED RECEPTORS ARE EXPRESSED IN AVIAN 
MUSCLE TISSUE AND CELLS 
 Using RT-PCR, a 411 bp and 832 bp partial ORX and ORXR1 cDNA corresponding to 
nucleotides 51–462 (GenBank accession no. AB056748) and 335–1145 (GenBank accession no. 
NM_001024584), respectively, were detected in the total RNA extracted from 3 wk-old male 
broiler chicken leg muscle (Fig. 1A) and quail muscle (QM7) cell lines (Fig. 2A). The same 
bands (size and sequences) were observed in the positive controls (brain, testis and ovary) (Figs. 
1A and 2A). The use of negative control (water instead of cDNA or RNA that was not reverse 
transcribed) did not produce any PCR product confirming the absence of genomic DNA 
contamination (Figs. 1A and 2A). Northern blot analysis revealed a single prepro-orexin mRNA 
signal (3.1 kb) in both brain and QM7 cell (Fig. 2C). Next, using a rabbit anti-mouse prepro-
orexin and a rabbit anti-rat orexin receptor 1 and 2 antibodies, Western blot analyses showed 
bands of 16, 48, and 51 kDa in chicken muscle and QM7 cells corresponding to prepro-orexin, 
ORXR1, and ORXR2, respectively (Figs. 1B and 2B). These molecular weights were observed 
in the positive controls (whole brain and hypothalamus) and correspond to those of prepro-orexin 
and ORXR1/2 found in mammalian brain and chicken gastroenteric tract. Immunofluorescence 
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staining demonstrated abundant immunoreactivity for orexin and its receptors in the cytoplasmic 
compartment of QM7 cells, which has been confirmed by Western blot using cell fractions (Fig. 
2, D–F). When the primary antibodies were replaced by isotype antibodies or nonimmune PBS 
solution, no reactivity could be observed (data not shown). 
3.4.2 SECRETION OF OREXIN IN QM7 CELLS 
 The first 33 amino acids of prepro-orexin exhibit characteristics of a secretory signal 
sequence (hydrophobic core followed by residues with small polar side chains) in combination 
with its presence in the circulation indicate that orexin is a secretory protein (4). To ascertain 
whether orexin is, in fact, secreted, QM7 cell monolayers were incubated in serum-free medium 
for 24 h, after which orexin levels in lysates (Fig. 2B) and medium (Fig. 3A) were assessed by 
SDS-PAGE and immunoblot analysis with antibody against prepro-orexin. Orexin was detected 
in both the cell lysate (Fig. 2B) and the medium from untreated or orexin-treated cells (positive 
control) (Fig. 3A). Consistent with the predicted molecular weight of orexin, the immunoreactive 
protein exhibited a mobility by SDS-PAGE corresponding to molecular mass of 16 KDa (Fig. 
3A). It is, however, noteworthy that a second band with higher molecular weight (~230 kDa) was 
detected in the medium and not in the cell lysate. Furthermore, the time course study of orexin 
secretion in QM7 cells showed that orexin steadily accumulated in the medium over 48 h period 
(Fig. 3B). Treatment of cells with brefeldin A, an inhibitor of translocation of secretory proteins 
from the endoplasmic reticulum to the Golgi apparatus (36), for 12 h blocked secretion of orexin 
into the medium leading to increased intracellular expression (Fig. 3C). 
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3.4.3 OREXINS REGULATE THE EXPRESSION OF ITS OWN SYSTEM IN QM7 CELLS 
 The effects of 10 and 100 nM of recombinant human orexin A (rORX-A) or B (rORX-B) 
on the expression (mRNA and protein) of ORX and its related receptors (ORXR1 and ORXR2) 
in QM7 cells are shown in Fig. 4. Treatment of QM7 cells for 24 h with either 10 or 100 nM 
rORX-A upregulated ORX and ORXR1, but not ORXR2, gene expression (P < 0.05; 
Fig. 4A). Treating cells with rORX-B downregulated ORX and ORXR2 and increased ORXR1 
mRNA levels (P < 0.05 Fig. 4C). ORX, ORXR1, and ORXR2 proteins showed the same 
expression patterns as their corresponding genes (Fig. 4, B and D). These effects seemed to be 
dose-dependent. 
3.4.4 OREXINS DIFFERENTIALLY REGULATE MITOCHONDRIAL-RELATED GENES 
AND THEIR TRANSCRIPTIONAL REGULATORS IN QM7 CELLS 
 The rORX-A and rORX-B treatments had differential effects on av-UCP, av-ANT, Ski, 
and NRF-1 expression, as shown in Fig. 5. Whereas rORX-A had no effect on av-UCP mRNA 
abundance (Fig. 5A), it downregulated the expression of av-ANT (mRNA and protein levels), 
Ski, and NRF-1 in a dose-dependent manner (Fig. 5, B–D). rORX-B, however, downregulated 
the expression of av-UCP and increased the expression of Ski and NRF-1 without altering the 
expression of av-ANT (Fig. 5, A–D). These changes coincided with a significant downregulation 
of PPARγ, PPARα, and FoxO-1 expression by both doses of rORX-A (Fig. 6, A, B, and E). A 
high dose of rORX-A significantly downregulated the expression of PGC-1β, and both doses did 
not alter PGC-1α mRNA abundance (Fig. 6, C and D). rORX-B, however, induced the 
expression of these transcription factors in a dose-dependent manner, but the effects were 
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statistically significant only for PGC-1β, PGC-1α, and FoxO-1 with the high dose (Fig. 6, C, D–
E). 
3.4.5 OREXINS REGULATE MITOCHONDRIAL BIOENERGETICS IN QM7 CELLS 
 Bioenergetics in QM7 cells treated with 10 and 100 nM of rORX-A and rORX-B were 
assessed by monitoring basal oxygen consumption rate (OCR) followed by sequential treatment 
of cells with oligomycin, FCCP, and antimycin A as shown in Fig. 7A. As described previously 
(27), the decrease in OCR following oligomycin (which blocks ATP synthase) reveals OCR 
attributed to ATP synthesis activity. Maximal OCR is revealed in response to the uncoupling 
compound FCCP, and the difference between maximal OCR and basal OCR (prior to 
oligomycin) represents mitochondrial oxygen reserve capacity that cells can draw upon when 
increased energy production is needed. Oxygen consumption that remains following treatment 
with antimycin A is attributed to nonmitochondrial OCR (i.e., OCR due to activities other than 
nonmitochondrial c oxidase activity, such as mitochondrial reactive oxygen species production, 
oxidase activities, etc.). The amount of OCR attributed to proton leak is determined by the 
difference between oligomycin and antimycin A-inhibited OCR. When the nonmitochondrial 
component of cellular OCR was subtracted and by setting maximal OCR following FCCP at 
100%, the effects of ORX-A and ORX-B on ATP synthesis, reserve capacity, and proton leak 
were determined and are presented in Fig. 7, B–D. ATP synthesis was slightly elevated by both 
orexins, but the effect was not statistically discernable (Fig. 7B). Analysis of reserve capacity 
indicated no effect of both doses of rORX-A and rORX-B (Fig. 7C); however, proton leak was 
decreased by 10 nM of rORX-A, and by 100 nM of rORX-B (P < 0.05, Fig. 7D). 
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3.4.6 OREXINS DIFFERENTIALLY REGULATE MITOCHONDRIAL BIOGENESIS IN 
QM7 CELLS 
 Mitochondrial DNA (mtDNA) replication and quantitation are a necessary component of 
mitochondrial biogenesis. MtDNA and mtSSBP1 expressions were measured in QM7 cells 
treated with orexins as shown in Fig. 9. In contrast to rORX-A, in which both doses significantly 
downregulated mtDNA and upregulated mtSSBP1 expression, rORX-B (high dose) significantly 
increased mtDNA expression without affecting mtSSBP1 levels (Fig. 9, A and B). Consistent 
with these observations and in contrast to rORX-A, rORX-B increased mitochondrial content as 
visualized with MitoTracker Red probe (Fig. 8). Neither rORX-A nor rORX-B affected the 
expression of the mitochondrial transcription factor TFAM (data not shown). The expression of 
Cox IV and Cox 5a genes, commonly used markers for mitochondrial mass and biogenesis, was 
determined. The high dose (100 nM) of rORX-A decreased Cox IV gene expression; however, 
the high-dose of rORX-B increased Cox IV and Cox 5a mRNA levels compared with untreated 
cells (P < 0.05, Fig. 9, C and D). 
3.4.7 OREXINS DIFFERENTIALLY REGULATE MITOCHONDRIAL DYNAMICS IN QM7 
CELLS 
 The expression of four genes related to mitochondrial fusion and three genes related to 
mitochondrial fission were measured as shown in Fig. 10. Recombinant ORX-B at high dose 
significantly induced the expression of MFN2, OPA1, and OMA1, but decreased the mRNA 
levels of MFN1 (Fig. 10, A–D). The same effect was observed at the protein levels (Fig. 10E). 
However, rORX-A significantly downregulated the expression of MFN1 and OMA1 with both 
doses, and OPA1 with the high dose, but did not affect that of MNF2 (Fig. 10, A–D). 
Interestingly, and in contrast to rORX-B, where no significant effects were observed, rORX-A 
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upregulated the expression of mitofission-related genes MTFP1, DNM1, and MTFR1 (P < 0.05, 
Fig. 10, F–H). 
3.5 DISCUSSION 
 The growing obesity epidemic has sparked numerous studies on the identification and the 
roles of feeding-related hypothalamic neuropeptides in the regulation of energy homeostasis. 
Orexins (A and B) or hypocretins (1 and 2) are multifunctional neuropeptides that bind to two 
receptors, ORXR1 and ORXR2, to regulate feeding behavior (56), sleep-wake cycle (41), 
circadian clock (6), and glucose and lipid metabolism in mammals (62). Such physiological roles 
in avian (nonmammalian vertebrate) species are not well defined yet, although orexins are 
expressed in several tissues, including hypothalamus (48), testis, ovary (49), and gastroenteric 
tract (3). Intracerebroventricular injection of orexin did not affect feeding behavior in neonatal 
chickens (24). Katayama et al. (33) reported that intracerebroventricular administration of orexin 
A induced arousal in layer-type chickens; however, Miranda et al. (45) could not find evidence 
that hypothalamic orexin plays a similar role. This suggests that orexins may have other 
physiological roles in avian species. 
 Because birds lack functional BAT, and avian muscle is the main site for thermogenesis 
(43), the recently discovered function of orexin in mammalian BAT development, 
differentiation, and thermogenesis (61) prompted our group to investigate whether orexin system 
is expressed in chicken muscle. 
 The present study is the first to report the presence of orexin system in chicken skeletal 
muscle and quail QM7 cells. We provided novel evidence that avian skeletal muscle expresses 
both prepro-orexin and its related receptors (ORXR1 and ORXR2). In birds, one type of orexin 
receptor (ORXR1) has been previously identified (49). In the present study, we used specific 
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primers for the predicted 2,170 nucleotide chicken ORXR2 that has 43% homology with the 
previous identified 1,869 nucleotide chicken ORXR1 and amplified only one band corresponding 
to the expected size and sequence by real-time PCR. Additionally, by using orexin and orexin 
receptor polyclonal antisera raised against the well-conserved NH2 terminal region of mouse 
ORX and the COOH and NH2 terminus of the rat ORXR1/2, we detected immunoreactivity to 
ORX, ORXR1, and ORXR2 in chicken muscle tissue and QM7 cells by Western blot and 
immunofluorescence staining, corroborating previous data in chicken intestine, stomach, and 
pancreas (3). Orexin receptor ORXR1 and two isoforms of ORXR2 (ORX2αR and ORX2βR) 
have been also shown to be expressed in mouse muscle (17). 
 The expression of orexin and its related receptors (ORXR1 and ORXR2) in avian muscle 
and the detection of orexin in culture media suggest that avian muscle might be a source for 
orexin production and secretion and indicate possible autocrine, paracrine, and/or endocrine 
roles. In support of this, rORX-A and rORX-B differentially regulate its own gene and protein 
expression. Although the underlying mechanism is still unknown, the divergent effects of orexin 
A and orexin B on orexin expression might be related to their structure (presence of disulfide 
bonds in orexin A and not in orexin B) and their different binding affinity to ORXR2, since they 
had similar effects on ORXR1 expression. In mammals, indeed, the ORXR1 preferentially binds 
orexin-A, whereas ORXR2 binds both peptides (orexin A and B), apparently with similar affinity 
(56). Interestingly, it is likely that ORXR2 and not ORXR1 mediated the activation of the 
dorsomedial and lateral hypothalamic neurons leading to the adaptive response (thermogenesis 
and physical activity) to diet restriction in rat (59). As we used here recombinant human orexins 
and chicken orexin A and B that showed approximately only 85% and 65% identity with the 
corresponding mammalian sequences (48), further binding studies are warranted. Moreover, the 
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potential involvement of the structure, the function of the cytoplasmic tails, and the 
desensitization of ORXR1/2 in the divergent effects of orexins are not ruled out. 
 In line with the aforementioned divergent effects, orexins differentially regulated the 
expression of mitochondrial-related genes (av-UCP, av-ANT, Ski, NRF-1) and their related 
transcription factors and coactivators (PPARα, PPARγ, PGC-1β, PGC-1α, and FoxO-1) with 
downregulation for orexin A and upregulation for orexin B. Such divergent effects of orexins on 
gastric acid secretion and arousal have been previously reported in rats and chickens, 
respectively (33, 52). In contrast to the well-known role of UCP1 in BAT thermogenesis, the 
function of av-UCP that is homologous to mammalian UCP2 and UCP3 is still under debate. We 
previously hypothesized that av-UCP might be involved in avian muscle adaptive thermogenesis 
and energy dissipation as heat based on its upregulation during cold exposure and after chronic 
treatment with glucagon (53). Teulier et al. (69), however, suggested that av-UCP might not be 
involved in heat production through mitochondrial uncoupling. Two other independent groups 
reported a possible role for av-UCP in mitochondrial reactive oxygen species (ROS) production 
(1, 54). As in mammals, the avian mitochondrial anion carrier ANT (also known as avATP/ADP 
carrier) has been reported to be involved in thermogenesis and mitochondrial ROS control (11, 
67, 70). 
 Mitochondria are responsible for producing over 90% of the ATP for the cell by 
oxidative phosphorylation associated with the electron transport chain (37), and mitochondrial 
dysfunction in skeletal muscle is closely associated with insulin resistance in mammals (50) and 
feed inefficiency in chickens (10). The alteration of mitochondrial-related genes and their 
transcriptional regulators indicated that orexin might control avian muscle mitochondrial 
dynamics and respiratory function. Mitochondria are constantly undergoing both fusion 
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(biogenesis) and fission (15). Fusion involves complete mtDNA replication; however, fission 
occurs when the existing copies of mtDNA are simply divided between the new fissioned 
mitochondria (15). In support of our above-mentioned hypothesis, orexins differently regulated 
mitochondrial dynamics-related genes. While rORX-B increased mitofusion, as indicated by the 
upregulation of MFN2, OPA1, and OMA1 gene expression, rORX-A promoted mitofission as 
reflected in the increased expression of MTFP1, DNM1, and MTFR1 genes. Despite the 
unchanged expression of TFAM (the direct regulator of mtDNA replication/transcription), the 
increased levels of mtDNA and CoxIV and Cox5a mRNA indicated that rORX-B might induce 
mitochondrial content and mass through other TFAM isoforms (22), TFAM posttranslational 
modifications (58), and/or other transcription factors (9). An increase in mitochondrial content 
following rORX-B treatment is also supported by the increased MitoTracker staining. 
 The effects of orexin on avian muscle mitochondrial dynamics are very likely mediated 
through NRF-1, Ski, and their related transcription regulators (PPARγ, PGC-1β, PGC-1α, and 
FoxO-1). Although their roles are not well defined in birds, the NRF-1 and Ski play a key role in 
mammalian mitochondrial biogenesis and respiratory function (75, 76). Mammalian NRF-1 is a 
direct target for PPARγ and PGC-1 (75). PGC-1 stimulates induction of NRF-1 gene expression 
and coactivates its transcriptional function on TFAM promoter (75). MFN2 expression has been 
shown to be controlled by two distinct regulatory mechanisms, including PGC-1α/estrogen-
related receptor (ERR) α- and PGC-1β/ERRα-dependent signaling pathways (13, 40, 64). FoxO-
1 has been shown to interact with heme oxygenase 1 (HMOX1) and regulate mitochondrial 
biogenesis and function through sirtuin 1 (SIRT1) and PGC-1 pathways (18). 
 To gain better insight into the physiological roles of orexins in avian muscle and to 
evaluate whether the alteration of mitochondrial dynamics impairs mitochondrial respiratory 
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function, we measured bioenergetics components in orexin-treated and untreated (control) QM7 
cells using extracellular XF-24 Flux analyzer. On the basis of our findings, orexin-induced 
mitochondrial fusion/fission seemed not to affect ATP synthesis. In mammals, the impact of 
mitochondrial dynamics on mitochondrial energization and function varied upon the 
experimental model (cell line) and conditions. For instance, inhibition of mitochondrial fusion by 
manipulation of MFN2/ OPA1 expression caused a reduction in mitochondrial membrane 
potential and activity of respiratory complexes. Overexpression of a truncated form of MFN2 
(Δ602–757) enhances mitochondrial metabolism independent of fusion activity (51); however, 
other MFN2 mutants did not induce metabolic alterations (68). Some OPA1 mutants showed 
impaired ATP synthesis driven by complex I substrates and decreased rates of mitofusion (77); 
however, other mutants showed normal mitochondrial activity and bioenergetics (65). One study 
(16) reported that overexpression of OPA1 did not modify mitochondrial metabolism in MEF 
cells. Emerging evidence indicated that alterations in mitofission-related proteins such as DNM1 
and FIS1 produced similar effects on mitochondrial metabolism (7). Together, these data 
indicated that specific mutations in mitochondrial dynamics-related genes alter mitochondrial 
metabolism. 
 Although we did not see any effect on ATP synthesis in the present study, we anticipate 
the possibility that mitochondrial dynamics might regulate mitochondrial metabolism via 
different pathways, including a direct “physical” effect of fusion/fission and/or downstream 
signaling cascades of dynamics-related genes that cause direct changes in the expression of 
oxidative phosphorylation subunits, as previously shown (51). Therefore, compensatory or 
feedback mechanisms between fusion-fission events or between fusion- and fission-related genes 
might be expected to maintain mitochondrial homeostasis and might explain the absence of 
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metabolic alteration after orexins treatments. In addition, it is possible that some mitochondria 
might be only tethered or connected but not completely fissioned or fusioned; thus, an additional 
level of complexity in the regulation of mitochondrial dynamics is likely to occur (74). Finally, 
we measured only a few genes, and further analysis of additional genes and proteins involved in 
mitochondrial network is required, and a demonstration of how they are regulated in vivo 
conditions is mandatory. 
 The findings of the present study are the first evidence of orexin system expression and 
secretion in muscle and unveil its important role in mitochondrial network. 
3.5.1 PERSPECTIVES AND SIGNIFICANCE 
 Orexins are originally identified as feeding-related hypothalamic neuropeptides that have 
effects on diverse processes, including obesity and diabetes. A major goal is to identify and 
unravel the mode of orexin action in these processes using different experimental models. In the 
present study, we used chickens as a model of choice because they are naturally hyperglycemic 
compared with mammals (38), insulin-resistant (2), lack of functional BAT (5), and prone to 
obesity (29). We provided evidence that orexin system is expressed in chicken muscle and plays 
a key role in mitochondrial dynamics. Because chicken muscle is the main site for thermogenesis 
and because mitochondrial functions are implicated in many (patho)-physiological processes, our 
findings open new vistas on the role of orexin in muscle energy metabolism. As genetic selection 
for rapid growth, driven by economic demands, have resulted in dramatic increase in body 
weight of broiler chickens arising from increased skeletal muscle mass, further studies 
investigating the role of orexin in muscle development, myogenesis, insulin sensitivity, and 
glucose uptake are warranted. Insights into the molecular mechanisms and physiological role of 
orexin in skeletal muscle are of uppermost interest not only in animal biology for health and feed 
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efficiency improvement, but also in molecular medicine for pathophysiological understanding 
and therapeutic perspectives. 
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3.7 TABLES AND FIGURES 
Table 3.1 Oligonucleotide primers used for the detection of target genes.  
Gene Accession Numbera Primer Sequence (5’  -->  3’) Orientation Product Size, bp 
PCR     
    ORX     AB056748 ATGGAGGTGCCCAACGCCAAGCTGC 
CAGGTCCTTCTCAGCGTGCTCCTGG 
Forward 
Reverse 
411 
    ORXR1 AB110634 AACCACCACATGAGGACAGTCACC 
CGCAGCACTATTGGCATATACAA 
Forward 
Reverse 
832 
    18S AF173612 CTGCCCTATCAACTTTCG 
CATTATTCCTAGCTGGAG 
Forward 
Reverse 
515 
QPCR     
    ORX  AB056748 CCAGGAGCACGCTGAGAAG 
CCCATCTCAGTAAAAGCTCTTTGC 
Forward 
Reverse 
67 
    ORXR1 AB110634 TGCGCTACCTCTGGAAGGA 
GCGATCAGCGCCCATTC 
Forward 
Reverse 
58 
    ORXR2 XM_004945362 AAGTGCTGAAGCAACCATTGC 
AAGGCCACACTCTCCCTTCTG 
Forward 
Reverse 
61 
    avUCP NM_204107 TGGCAGCGAAGCGTCAT 
TGGGATGCTGCGTCCTATG 
Forward 
Reverse 
   59 
    avANT AB088686 GCAGCTGATGTCGGCAAA 
CAGTCCCCGAGACCAGAGAA 
Forward 
Reverse 
56 
    NRF1 NM_001030646 GGCCAACGTCCGAAGTGAT 
CCATGACACCCGCTGCTT 
Forward 
Reverse 
55 
    Ski  M28517 GGCCCTGCTGCTTTCTCA  
AGGTTCCGCTGGGTCTTTG 
Forward 
Reverse 
75 
    FoxO1 NM_204328 GCCTCCTTTTCGAGGGTGTT 
GCGGTATGTACATGCCAATCTC 
Forward 
Reverse 
64 
    PPARα AF163809 CAAACCAACCATCCTGACGAT 
GGAGGTCAGCCATTTTTTGGA 
Forward 
Reverse 
64 
    PGC-1β XM_414479 TTGCCGGCATTGGTTTCT 
CACGGGAAGCCACAGGAA 
Forward 
Reverse 
66 
    PPARγ NM_001001460 CACTGCAGGAACAGAACAAAGAA 
TCCACAGAGCGAAACTGACATC 
Forward 
Reverse 
67 
    Cox5a XM_001233020 GCGTGCAGACGGTTAAATGA 
TCCTTCACCACCTCCAGAATG 
Forward 
Reverse 
59 
    CoxIV NM_001030577 CGGTCGGCAGGATGTTG 
AGGGCTCTTCTCCCGATGA 
Forward 
Reverse 
55 
    mtDNA X52392 ACACCTGCGTTGCGTCCTA 
ACGCAAACCGTCTCATCGA 
Forward 
Reverse 
58 
    mtSSBP1 NM_001278007 CACAGACAGGTGATATCAGTCAGAAG 
GAGGCCTGGTCTGAAGACAGA 
Forward 
Reverse 
65 
    TFAM NM_204100 GAACAGCGGCCAAAAAAGAA 
ACGCAGCGAAGCTTTGGA 
Forward 
Reverse 
60 
    PGC-1α NM_001006457 GAGGATGGATTGCCTTCATTTG 
GCGTCATGTTCATTGGTCACA 
Forward 
Reverse 
62 
    MFN1 NM_001012931 CGGTGGTTTTGAGCCCATT 
GAAGCCTGGCACCCAAATC 
Forward 
Reverse 
57 
    MFNF2 XM_004947503 ATGTGCCTGTGACACGTTCAC 
TCGAGTGTCAGGCAGCTTCTT 
Forward 
Reverse 
63 
    DNM1 XM_001233249 GAACTTTCGCCCCGATGA 
TGGACCATCTGAAGCAGAGCTT 
Forward 
Reverse 
57 
    OPA1 NM_001039309 CCCAAGCAGGATCCAACAA 
AACAACTGCAAAGTAACCCAAAGC 
Forward 
Reverse 
73 
    OMA1 XM_422503 TCACTATGATTTGGGCCATCTG 
GATCCGCTGGCCAACAAC 
Forward 
Reverse 
59 
    MTFP1 XM_004934441 CCGCCATCCCTGTCATCA 
ATGCTGGAATCCATCAGGAAA 
Forward 
Reverse 
64 
    MTFR1 NM_204543 CAGATCAGAAGTGTGGTCGAAAAC 
AATGTCCAGGCTGATGTAGTTCAC 
Forward 
Reverse 
65 
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Table 3.1 (Cont’d).  
Gene Accession Numbera Primer Sequence (5’  -->  3’) Orientation Product Size, bp 
    MFF1 XM_001233529 TGGAGTACACCGAAGGAATCAGT 
TGAGGAGCCACTTTGAGTTTCTC 
Forward 
Reverse 
64 
    18S AF173612 TCCCCTCCCGTTACTTGGAT 
GCGCTCGTCGGCATGTA 
Forward 
Reverse 
60 
aAccession numbers refer to Genbank (National Center for Biotechnology Information). 
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Figure 3.1 Prepro-orexin and its related receptor are expressed in broiler chicken muscle. A: 
total RNA (1 µg) was reverse transcribed and subjected to RT-PCR, as described in 
MATERIALS AND METHODS. Brain, testis, and ovary were used as positive controls. B: 70 
µg total protein extracted from each tissue were electrophoresed and blotted onto polyvinylidene 
difluoride membrane. Preproorexin (ORX) and orexin receptor 1 (ORXR1) expression was 
detected by immunoblot using rabbit anti-mouse ORX and rabbit anti-rat ORXR1 antibodies. 
Hypothalamus and brain were used as positive controls. The figure is a representative picture 
from one animal. 
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Figure 3.2 Characterization of ORX and its receptors (ORXR1/2) in QM7 cell line. A: RT-PCR. 
Total RNA (1 µg) was isolated from chicken brain and QM7 cells and subjected to RT-PCR, as 
described in MATERIALS AND METHODS. B and E: Western blot. Total, nuclear and 
cytoplasmic protein were electrophoresed and blotted onto PVDF membrane. ORX and 
ORXR1/2 were detected using rabbit anti-mouse ORX and rabbit anti-rat ORXR1/2 antibodies. 
Nucleolin was used as a positive control for the nuclear fraction. C: Northern blot. Total RNA 
(10 µg) was separated by agarose gel electrophoresis and transferred to a nylon membrane and 
hybridized with specific biotin-labeled DNA probe toward chicken ORX, and 18S. Hybridization 
signals were detected by FluorChem M MultiFluor system. D: immunofluorescence staining. 
Intracellular ORX system distribution visualized by fluorescent microscope in the presence of a 
secondary antibody conjugated with Alexa Fluor 488 (green) and DAPI (blue). F: real-time 
quantitative PCR (qPCR). RNA was isolated from different cellular fraction (total, cytoplasmic, 
and nuclear) and subjected to RT-qPCR in the presence of primers specific for chicken ORX and 
ORXR1/2, as described in MATERIALS AND METHODS. 
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Figure 3.3 Secretion of orexin by QM7 cells. A: cell monolayers were incubated in serum-free 
medium with or without rORX-B (100 nM) for 24 h. B: QM7 cells were incubated in serum-free 
medium for different time periods. C: cells were incubated in serum-free medium with or 
without brefeldin A (0.3 µg/ml) for 12 h. Medium and/or cell lysates were subjected to 
immunoblot analysis using anti-orexin antibody, as described in MATERIALS AND 
METHODS. 
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Figure 3.4 Effect of orexin treatment on orexin system expression in QM7 cells. Cells were 
treated with 0 (control), 10, or 100 nM of recombinant orexin A and B for 24 h. Total RNA and 
protein were isolated as described in MATERIALS AND METHODS. Relative expression of 
ORX and ORXR1/2 was determined by QPCR using 2-ΔΔCt method (A, C). Protein levels were 
measured by Western blot analysis (B, D). Data are expressed as means ± SE (n = 6). 
*Significant difference between orexin-treated and control cells (P < 0.05). 
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Figure 3.5 Effect of orexin treatment on mitochondrial-related genes in QM7 cells. Cells were 
treated with recombinant orexin A or B (10 and 100 nM) for 24 h and the relative abundance of 
avian (av)-UCP (A), av-adenosine nucleotide translocator (ANT; B), Ski (C), and nuclear 
respiratory factor 1 (NRF-1; D) were determined by QPCR. Untreated cells were used as control. 
Protein levels of av-ANT were measured by Western blot analysis. Data are expressed as means 
± SE (n = 6). *Significant difference between orexin-treated and control cells (P < 0.05). 
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Figure 3.6 Effect of orexin treatment on mitochondrial-transcriptional regulators in QM7 cells. 
The relative expression of peroxisome proliferator-activated receptor γ (PPARγ (A), PPARα (B), 
PGC-1β (C), PGC-1α (D), and FoxO-1 (E) was determined by real-time PCR. Protein levels of 
PGC-1α were determined by Western blot analysis. Data are means ± SE; n = 6. *Significant 
difference between orexin-treated and control cells (P < 0.05). 
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Figure 3.7 Effect of orexin treatment on mitochondrial bioenergetics in QM7 cells. A: oxygen 
consumption rate (OCR) was determined using XF24 Flux Analyzer. Bioenergetic parameters, 
including OCR due to ATP synthesis (B), mitochondrial oxygen reserve capacity (C), and proton 
leak (D) were determined as described in MATERIALS AND METHODS. The values represent 
the means ± SE (n = 6). *Significant difference between orexin-treated and control cells (P < 
0.05). 
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Figure 3.8 Effect of orexin treatment on mitochondrial distribution in QM7 cells. Cells were 
cultured in chamber slides and treated with 100 nM of rORX-A or rORX-B for 24 h. 
Mitochondria were visualized with MitoTracker Red CMX Ros (75 nM) under a fluorescent 
microscope. Representative images acquired and deconvoluted are shown. DIC, differential 
interference contrast. DAPI, 4’,6-diamidino-2-phenylindole. 
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Figure 3.9 Effect of orexin treatment on mitochondrial DNA and mass in QM7 cells. QM7 cells 
were treated with orexins (10 and 100 nM) for 24 h, as described in MATERIALS AND 
METHODS. The levels of mtDNA (A) and the relative expression of mtSSBP1 (B), 
mitochondrial markers CoxIV (C), and Cox5a (D) were determined by real-time PCR. The 
values represent the means ± SE (n = 6). *Significant difference between orexin-treated and 
control cells (P < 0.05). 
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Figure 3.10 Effect of orexin treatment on mitochondrial dynamics-related genes in QM7 cells. 
QM7 cells were treated with orexins (10 and 100 nM) for 24 h, as described in MATERIALS 
AND METHODS. The relative expression of four genes involved in mitochondrial fusion, 
MFN1 (A), MFN2 (B), OPA1 (C), OMA1 (D) and three genes involved in mitochondrial fission, 
MTFP1 (F), DNM1 (G), and MTFR1 (H) was determined by real-time PCR. The protein levels 
of MFN1, MFN2, and OPA1 were determined by Western blot analysis (E). The values represent 
the means ± SE (n = 6). *Significant difference between orexin-treated and control cells (P < 
0.05). 
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4.1 ABSTRACT 
Background: The objective of this study was to determine mRNA expression of genes involved 
in muscle development and hypertrophy, and the insulin receptor signaling pathway in breast 
muscle associated with the phenotypic expression of feed efficiency (FE).  Breast muscle 
samples were obtained from Pedigree Male (PedM) broilers (~8 wk old) that had been 
individually phenotyped for FE between 6 and 7 wk of age. The high FE group gained more 
weight but consumed the same amount of feed compared to the low FE group.  Total RNA was 
extracted from breast muscle (n = 5 per group) and mRNA expression of target genes was 
determined by real-time quantitative PCR.  
Results: The results indicate that several genes known to enhance muscle formation and growth 
[AMP-activated protein kinase alpha 1 and 2 (AMPKα1, AMPKα2), heat shock 70 kDa protein 
(HSP70), myogenin, creatine kinase, neutrophil cytosolic factor 2 (NCF2), mitogen-activated 
protein kinase kinase 6 (MAP2K6), mitogen-activated protein kinase kinase kinase 7 
(MAP3K7)] were upregulated (P < 0.05) in high FE, whereas genes known to inhibit muscle 
hypertrophy, differentiation, and fiber size [myostatin, caveolin-3, activin receptor II B, Smad 2, 
Smad 3, IGF-binding protein 3 (IGFBP-3)] were downregulated in the muscle of high FE PedM 
broilers compared to the Low FE phenotype.  Differentially expressed genes in the insulin 
signaling pathway included insulin receptor substrate 1 (IRS-1) and regulatory-associated protein 
of mechanistic target of rapamycin (RAPTOR) that were upregulated (P < 0.05) whereas SHC-
transforming protein 1 (SHC-1) and glucose transporter 8 (GLUT-8) that were downregulated (P 
< 0.05) in high compared to Low FE breast muscle.  Increased abundance of eukaryotic 
translation and initiation genes (determined by binomial distribution analysis) from RNAseq data 
was observed in the high FE compared to the low FE breast muscle.  
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Conclusion: These findings suggest that the expression of genes involved in muscle 
development-differentiation and protein synthesis gene expression was enhanced in breast 
muscle of PedM broilers exhibiting a high FE phenotype compared to those exhibiting a low FE 
phenotype. 
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4.2 INTRODUCTION  
 Feed efficiency (FE) is one of the most important genetic traits in animal production since 
feed costs account for roughly 70% of the total required to bring an animal to market weight [1]. 
In a Pedigree Male (PedM) broiler FE model, animals with Low FE exhibited higher mitochondrial 
reactive oxygen species (ROS) production and higher oxidative stress compared to those with high 
FE (see review [2]).  Although ROS causes oxidation at high levels, low levels of mitochondrial 
ROS are important in signal transduction and control various physiological processes affecting 
cell growth and proliferation (reviewed by [3, 4]).  Therefore, it was hypothesized that inherent 
gene expression in the low FE phenotype is modulated by mitochondrial ROS production [5, 6].  
       To develop a comprehensive understanding of the cellular basis of FE, global gene and 
protein expression studies were conducted on breast muscle obtained from PedM broilers 
exhibiting high and low FE phenotypes [6-8].  These studies have provided insight into 
fundamental mechanisms of FE in muscle but have also provided paradoxical findings.  For 
example, despite clear enrichment of cytoskeletal or muscle fiber gene expression occurring in 
the low FE phenotype [6, 8], myostatin (MSTN), which is well known to inhibit muscle 
development ([9, 10] reviewed by [11]), was up-regulated in breast muscle of low FE PedM 
broilers [12].  The expression of adenosine monophosphate-activated protein kinase 1 (AMPK), 
which is a sensor of energetic status in the cell, was elevated in a cDNA microarray in muscle of 
the high FE PedM phenotype ([13].  AMPK activates energy production pathways (e.g. 
glycolysis, lipolysis, oxidative phosphorylation) and inhibits energy consuming pathways (e.g. 
lipogenesis, protein synthesis) (reviewed by [14]).  Thus, the increased expression of AMPK in 
the high FE phenotype could conceivably be inhibiting protein synthesis that appears to run 
counter to the fact that these animals gained more body weight compared to the low FE PedM 
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phenotype [5, 6].   Therefore, the objective of this study was to conduct targeted analysis of 
genes involved in muscle development, protein synthesis, and energy metabolism; particularly 
genes in part of the myostatin and insulin signaling pathways that are differentially expressed in 
breast muscle obtained from PedM broilers exhibiting a high or low FE phenotype. 
4.3 MATERIALS AND METHODS 
4.3.1 TISSUES AND ANIMALS 
 Breast muscle analyzed in this study were from the same experiment in which 
transcriptomics [6, 8] and proteomics [7] investigations have been conducted. The Pedigree Male 
(PedM) broilers were individually phenotyped for FE as previously described [5]. Briefly, FE 
(amount of body weight gain/amount of feed consumed) was determined between 6 and 7 wk of 
age on a group of 100 PedM broilers housed in individual cages.  Birds were provided access to 
feed and water ad libitum. All birds received the same corn-soybean based diet (20.5% protein, 
3,280 kcal/kg) ad libitum during the feed efficiency trial. From this group of 100, birds with the 
highest and lowest FE were selected. Feed efficiencies for the low- and high-FE groups (n = 6 
per group) in the present study were 0.46 + 0.01 and 0.65 + 0.01, respectively.  In the high FE 
group, greater efficiency was obtained by greater weight gain without a difference in feed intake 
during the week of phenotyping. The difference in mean FE (0.19) between the groups is 
identical to that reported in our initial investigation [5]. Birds were humanely euthanized, breast 
muscle tissue (pectoralis major) was quickly excised and flash frozen in liquid nitrogen, and 
stored at -80 ºC. All procedures for animal care complied with the University of Arkansas 
Institutional Animal Care and Use Committee (IACUC Protocol #14012). 
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4.3.2 RNA ISOLATION AND QUANTITATIVE REAL-TIME PCR 
 Total RNA was extracted by TRIzol reagent (Life Technologies, Thermo Fisher 
Scientific, Carlsbad, CA) according to the manufacturer’s recommendations, DNase-treated, and 
reverse-transcribed (Quanta Biosciences, Gaithersburg, MD). The concentration and purity of 
RNA were determined for each sample using a Take 3 microvolume plate and a Synergy HT 
multimode microplate reader (BioTek, Winooski, VT). The reverse-transcription (RT) products 
(cDNAs) were amplified by real-time quantitative PCR (7500 real-time PCR system, Applied 
Biosystems, Thermo Fisher Scientific, Foster City, CA) with Power SYBR Green Master Mix 
(Applied Biosystems). Oligonucleotide primers used in this study and genes that were examined 
are provided in Table 1. 
4.3.3 STATISTICAL ANALYSIS 
 Comparison of mean expression values for qRT-PCR between the high and low FE 
groups were made using student t-test.  Differences were considered significant at P < 0.05 with 
some qualifications.  Binomial distribution analysis was used as previously described to assess 
differences in the number of genes associated with eukaryotic initiation and translation factors 
involved in protein synthesis of unreported data (see Table 2) contained in a transcriptomic 
dataset [8, 15].  Briefly, the numbers of molecules in which average values were numerically 
higher (H) or lower (L) in breast muscle of the high FE compared to the low FE PedM phenotype 
were determined and used in the exact binomial distribution analysis test offered in the 2010 
version of Microsoft ExcelTM.  There was no cutoff based on significant or fold difference in 
expression for a given transcript involved in the bionomial distribution analysis that was 
conducted. 
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4.4 RESULTS AND DISCUSSION  
 The major goal of this study was to conduct targeted gene expression analysis using qRT-
PCR to confirm results and extend the understanding of fundamental mechanisms of FE 
presented in transcriptomic and proteomic studies conducted in breast muscle of PedM broilers 
exhibiting high and low FE phenotypes [6-8, 16]. The discussion below will be directed to 
results associated with a) muscle development and myostatin signaling, and b) nutrient sensing, 
protein synthesis and insulin signaling followed by a summary that will incorporate information 
from a transcriptomic dataset obtained previously [8] but not reported. 
4.4.1 MUSCLE DEVELOPMENT AND MYOSTATIN SIGNALING 
 The mRNA expression of MYOG, MAP2K6, MAP3K7, HSP70, and NCF2, genes 
that promote muscle development and differentiation, were higher in high FE compared to low FE 
broilers (Figure 1). Myogenin (MYOG), a key regulatory transcription factor involved muscle 
development during myogenesis [17-19], was upregulated in the high FE phenotype (Figure 1A). 
Previous studies in broilers reported a positive relationship between increased breast muscle 
weight and increased mRNA levels of MYOG [20, 21].  Myozenin (Myoz-2), however, was not 
differentially expressed (Figure 1B). Myozenin (Myoz-2) is a protein associated with actin and 
myosin found on the z-line in skeletal muscle and part of the contractile apparatus [22].  In a recent 
transcriptomic study, Myoz-2 expression was down-regulated in breast muscle of the high FE 
PedM broiler phenotype [8].  We do not have an explanation for this discrepancy in expression 
between the present study and Bottje et al. [8] at this time.  
Expression of two mitogen activated kinase enzymes, MAP2K6 and MAP3K7 involved in 
muscle development and response to environmental stress (see review [23]), were elevated in the 
high FE phenotype (Figure 1C and 1D).  Specifically, MAP2K6 activates p38 MAP kinase and 
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plays an important part in its signal transduction pathway [24] ; whereas MAP3K7 is involved in 
activation of nuclear factor kappa β (NFκB) in addition to other MAP kinases [25].  There were 
no differences in expression of MAP2K1, MAP2K2, and MAP2K4 however (data not shown).  
Expression of CAV-3 mRNA was downregulated in the high FE phenotype in this study 
(Figure 1E). CAV-3 is a member of the caveolin family, and serves as the muscle-specific isoform 
of the protein [26]. Mutations and expression differences of CAV-3 can result in certain muscle 
myopathies [27]. Caveolae are sub-cellular structures that function in cell signaling by aiding 
internalization of hormonal signals after the hormone binds to the target receptor on the cell 
surface. Zhu et al. [28] indicated that CAV-3 expression was upregulated during muscle 
hyperplasia when compared to expression levels during muscle hypertrophy in pigs. Zhu et al. [28] 
hypothesized that CAV-3 might be used as a genetic marker for meat production in swine. Altered 
CAV-3 expression, however, may be detrimental to muscle development. Smythe and Rando [29] 
reported that both increases or decreases in CAV-3 expression in mouse muscle cells made them 
more susceptible to oxidative stress and decreased survival through PI(3)K/Akt signaling. Thus, 
the up regulation of CAV-3 in the low FE phenotype compared to the low FE phenotype would 
potentially enhance muscle development as indicated by Zhu et al. [28] but could also contribute 
to higher oxidative observed in the low FE PedM broiler [2] as indicated by Smythe and Rando 
(2006) [29].  Since the expression of CAV-1 protein, which is involved in insulin signaling (see 
below), was elevated in the high FE breast muscle [7] it is not clear what role the CAV1 and CAV3 
genes are contributing to the PedM broiler FE model in the present study.    
Heat shock protein 70 (HSP70) mRNA expression was elevated in the high FE breast 
muscle (Figure 1F).  This increase might be beneficial for muscle function as HSP70 has been 
reported to maintain muscle fiber integrity and enhance muscle regeneration and recovery from 
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damaging stress stimuli [30]. HSP70 is responsible for correct folding and assembly of nuclear-
encoded proteins targeted for import into the mitochondria where they assemble with 
mitochondrial DNA encoded proteins [31]. HSP70 is also an important chaperone for proteins 
encoded by mitochondrial DNA [32].  Previously, we reported that HSP90 gene expression was 
elevated in muscle of the low FE phenotype and hypothesized this elevation was a response to 
higher oxidative stress in these animals [13], whereas HSPB2 (heat shock p27 kDa protein 2) 
protein expression was elevated in the high FE breast muscle [7].  Thus, there appears to be distinct 
differences in expression of different members of the family of heat shock proteins in the high and 
low FE phenotypes. The elevation of HSP70 gene expression observed in the present study could 
be beneficial for muscle integrity and mitochondrial function.   
Neutrophil cytosolic factor 2 (NCF2) encodes a subunit of NADPH/NADH oxidase and is 
a critical component of NADPH oxidase 2 (NOX2) [33]. NCF2 was elevated in high FE breast 
muscle in the present study (Figure 1G) which concurs with findings in commercial broilers [34]. 
Similarly, NOX2 generates superoxide in the sarcoplasmic reticulum and is a major source of 
oxidative stress in muscle [33, 35].  NOX2 is a downstream target of nuclear factor erythroid 2-
like 2 (NFE2L2) which coordinates antioxidant response to oxidative stress by activating 
expression of genes that contain an antioxidant response element in their promoter regions [36, 
37].   From downstream target expression analysis, NFE2L2 was predicted to be activated in 
animals with high FE [7, 34].   
Expression levels of the inhibitory gene MSTN (a member of the TGF-β family), one of 
its receptors (ActRIIB), and two transcription factors of MSTN signaling, SMAD2 and SMAD3, 
were elevated in the low FE compared to high FE breast muscle (Figure 2).   In the cDNA 
microarray study [6, 13], data analyses using Ingenuity Pathway Analysis (IPA) software predicted 
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that several target molecules and mechanisms may contribute to differences in muscle growth, 
development, and differentiation between the high and low FE phenotype. Myostatin was 
downregulated in a microarray dataset in the high FE phenotype (i.e. upregulated in low FE 
phenotype; [12]). Myostatin is a member of the TGF-β family of molecules and is a strong negative 
regulator of skeletal muscle growth [9, 10] and differentiation and proliferation of turkey satellite 
cells [38]. The expression of the MSTN antagonist, FSTN, was not different between the two 
phenotypes (Figure 2B).  Studies investigating the relationship between MSTN and growth 
performance in broilers show that MSTN is a polymorphic gene in which different alleles of the 
gene can affect performance [39-41]. Thus, differences in FE in the PedM broiler line in this study 
could be attributed in part to different haplotypes of the MSTN gene.  Figure 3, adapted from Lee 
and Glass [42], summarizes the initial steps in MSTN signaling expression in the present study 
that would potentially exert a negative effect on muscle hypertrophy and differentiation in the low 
FE phenotype. 
4.4.2 ENERGY SENSING 
 In the present study, both isoforms of the catalytic subunit of 5’AMP activated 
protein kinase (AMPKα1 and AMPKα2) were upregulated in the high FE phenotype (Figure 4A 
and 4B) which verifies the previous results [13].  AMPK was also predicted to be activated in 
the high FE PedM phenotype in a proteomics study conducted on the same set of tissues [7].   
AMPK expression increases in response to low energy levels  (sensed by an increase in the 
AMP:ATP ratio) and stimulates ATP production by increasing energy-producing reactions (e.g. 
oxidative phosphorylation and glycolysis) and inhibiting pathways that consume ATP (e.g. fatty 
acid synthesis and gluconeogenesis) [43, 44]. Upregulation of AMPK stimulates mitochondrial 
biogenesis and mitochondrial electron transport chain activity [43-46].  
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Interestingly, creatine kinase (muscle isoform, CKM) gene expression was elevated in the 
high FE phenotype (Figure 4C) which is opposite to a decrease in CKM protein expression in the 
high FE phenotype [7].  The reason for this discrepancy is not apparent but gene and protein 
expression often do not go hand in hand. Increased expression of several proteins suggests that the 
muscle of the high FE phenotype PedM broiler may have enhanced capabilities for mitochondrial 
oxidative phosphorylation as well as the ability to shuttle creatine and phosphorylated creatine in 
and out of mitochondria [7, 47].   
4.4.3 PROTEIN SYNTHESIS 
 When active, the mechanistic target of rapamycin complex 1 (mTORC1) complex 
has many functions that include promoting cell growth by modulating gene transcription and 
increasing protein synthesis [48]. The mTOR pathway was hypothesized to play a role in the 
phenotypic expression of feed efficiency due in part to upregulation of the mTORC1 complex in 
breast muscle of the high FE phenotype [12] and mTOR expression was reported to be higher in 
the high FE compared to the low FE phenotype [49]. Two major components of mTORC1 complex 
are mTOR and regulatory associated protein of mTOR (RAPTOR) [50]. In the present study, 
RAPTOR mRNA expression was upregulated (P < 0.05) but mTOR was moderately 
downregulated (P < 0.08) in the high FE phenotype (Figure 4D and 4E).  It is possible that the 
increase in RAPTOR gene expression could have a positive effect on mTOR protein expression 
[50].  We do not have an explanation for the discrepancy of mTOR expression in this study and 
that of Piekarski [49] at this time.  
Key downstream targets of mTORC1 that enhance protein synthesis are p70S6k, and 
eukaryotic translation initiation factor 4E (EIF4E).  The expression of p70S6k, which is activated 
by insulin and refeeding [51], was higher in the low FE birds (p < 0.08) (Figure 4F). In humans, 
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mTOR expression is dysregulated during disease states such as cancer, diabetes, and heart disease 
[52] and can affect the expression of downstream genes involved in insulin signaling. Therefore, 
it is possible that elevated mitochondrial ROS production reported in the low FE phenotype [5], 
may partially explain the moderate upregulation of mTOR and p70S6k seen in those birds. This 
observation may also hold true for PRKAR1A and GLUT-8, two other members of the insulin 
signaling pathway that were upregulated in the low FE phenotype (see below).  A definitive 
characterization of the mTOR pathway in this PedM broiler model of feed efficiency will require 
protein expression analysis that includes the measurement of phosphorylated proteins which is 
beyond the scope of the present study. It should be pointed out that although mTOR was detected 
in western blots of broiler breast muscle, the phosphorylated mTOR was not detected [49].   
Although there was no difference in mRNA expression of EIF4E in the present study (data not 
shown), binomial distribution analysis of gene expression of a recent RNAseq dataset  [8] revealed 
a significant skew (Binomial distribution P value = 0.00001) favoring eukaryotic initiation and 
elongation factors in the high FE phenotype (Table 2).  Similarly, a genetic architecture favoring 
ribosome assembly and protein translation also was present in the high FE phenotype breast muscle 
[15]. These components of protein translation in the context of our feed efficiency model will be 
described in greater detail below (see Figure 6, and Summary). 
4.4.4 INSULIN SIGNALING 
 Targeted expression of genes associated with insulin signaling are presented in 
Figure 5. Insulin signaling and its pleiotropic effects on gene expression and muscle development 
in chickens is not as thoroughly understood and differs in certain ways when compared to 
mammals [53].  Unlike mammals, in chicken muscle only SHC-1 (not IRS-1) is activated by 
changes in nutritional status, suggesting that chickens have a tissue-specific regulation of insulin 
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signaling that is yet to be fully understood [54, 55]. Although there was no difference insulin 
receptor gene expression (data not shown), insulin-like substrate 1 (IRS-1) was upregulated in the 
high FE birds (Figure 5A), which concurs with the predicted activation of IRS-1 reported by Kong 
et al. [7] (2016). Additionally, insulin signaling requires insulin receptor endocytosis and is 
particularly dependent on CAV-1 [56].  CAV-1 protein expression was 9 fold higher in the high 
FE compared to low FE breast muscle [7] and could be instrumental in facilitating insulin signaling 
in the high FE PedM broiler.     
It has also been suggested that p70S6k is involved in a negative feedback that inhibits IRS-1 
activation by phosphorylating its serine residues [57]. Since p70S6k was marginally upregulated 
(P < 0.08) in the Low FE phenotype in the current study, it may be inhibiting IRS-1 activity, and 
thus increased SHC-1 expression (Figure 5B) may help to maintain the insulin signaling pathway 
in low FE. Both IRS-1 and SHC-1 are activated by tyrosine phosphorylation activity mediated by 
phophoinositide-3 kinase (PI3K) when insulin binds to the insulin receptor.   There were no 
differences in PI3K expression in the present study, however (data not shown). While IDE plays a 
role in insulin signaling and insulin activity [58, 59], a mitochondrial form of IDE is capable of 
cleaving mitochondrial leader signals of nuclear DNA-encoded mitochondrial proteins [60], thus 
making the enzyme important in mitochondrial function. Although we observed higher IDE 
protein expression in the high FE phenotype [7], IDE gene expression was not differentially 
expressed in the present study (data not shown).   The upregulation of anti-proliferative IGFBP-3 
in the low FE phenotype (Figure 5C) concurs with Zhou et al. [34] (2015). It has been reported 
that IGFBP3 may modulate the interaction of IGFs in the extracellular matrix [61].  Spangenburg 
et al. [62] (2003) reported that IGFBP3 (both gene and protein) was detected in rat soleus muscle 
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(Type 1 muscle fiber) but not in Type I and II muscle fibers in gastrocnemius muscle. IGFBP3 
was also demonstrated to play a role in differentiation in human myoblasts [63]. 
4.5 SUMMARY 
 Figure 6 provides a summary of results by combining the mRNA expression data 
presented above (Figure 1-5) with findings obtained from previous global expression studies 
conducted on the same group of animals used in the present study [7, 8].   Genes shown with a 
solid color (pink, green, or gray) are ones that were up-regulated, down-regulated or not different, 
respectively, in the high compared to the low FE phenotype.  Genes or processes shown with 
hatched or dotted fill depict findings from previous studies as described below.   
The down-regulation of Smad 2,3 in the high FE phenotype could result in less inhibition 
of muscle development relative to the low FE muscle phenotype.  Rictor was predicted to be 
inhibited in the high FE based on expression of downstream target molecules in a proteomics 
dataset obtained from the same groups of high and low FE PedM broilers [7]. The combined effects 
of down-regulation of Smad 2,3 and predicted inhibition of Akt could be hypothesized to lower 
the inhibition of Rheb through the intermediary components TSC1 and TSC2. We did not measure 
TSC1 and 2 or Rheb in the present study; TSC1 and 2 were not differentially expressed in 
transcriptomic data ([8], unreported observation).  The upregulation of Raptor (a key step in 
initiating protein synthesis) in the high FE phenotype could hypothetically enhance protein 
synthesis.  It should be noted that in a previous transcriptomic study [12], mTORC1 was 
upregulated in the high FE phenotype.  Increased abundance of genes associated with eurkaryotic 
translation and initiation (see Table 2) combined with increased abundance of genes and proteins 
associated with ribosome biosynthesis and mRNA translation that we reported previously [8] could 
foster the infrastructure needed to support protein synthesis in the high FE phenotype. 
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There also appears to be a number of components that would favor mitochondrial energy 
production and an energetic infrastructure in the high FE phenotype.  PGC1a was predicted to be 
activated in the proteomics study reported previously [7]. Components of the creatine phosphate 
shuttling between mitochondria and the cytosol including VDAC, ANT and mitochondrial creatine 
kinase (mt-CK) were upregulated in the high FE phenotype [47]. Gene expression of the muscle 
isoform of CK (CKM) was elevated in the high FE phenotype in the present study as was the 
expression of the brain isoform of CK (CKB) protein [47].  However, the CKM protein was 
downregulated in the high FE phenotype [47].  Enzyme kinetic studies conducted on the 
mitochondrial and cytosolic fractions from high and low FE phenotypes may be needed in order 
to fully characterize this system.  Nonetheless, better coupling of high FE compared to low FE 
mitochondria that includes lower mitochondrial ROS production and oxidative stress [2, 5] 
indicates that mitochondrial energetic capabilities are enhanced in the high FE phenotype. 
Enhanced production of mitochondrial oxidative phosphorylation in the high FE phenotype would 
help support the energetic demand associated with protein synthesis that in turn would support 
muscle development. 
The increased expression of NCF2, Myog, Map3K7 and Map2K6 combined with reduced 
expression of CAV3 and Smad 2,3 would all exert positive effects on muscle development in the 
high FE phenotype.  Although Map4K4 was not differentially expressed in the present study, 
Map2K4 was predicted to be inhibited in the high FE phenotype based on downstream expression 
of proteins [7].  The down regulation of IGFBP3 in the high FE phenotype would exert a negative 
effect on muscle development, however. 
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4.7 TABLES AND FIGURES 
Table 4.1 Oligonucleotide for quantitative reverse transcription polymerase chain reaction (qRT-PCR) primers. 
Gene 
Symbol 
Gene  
Name  
Accession Numbera Primer Sequence (5’ ➔ 3’) Orientation Product 
Size (bp) 
ActRIIA Activin NM_205367.1 GCCATCTCACACAGGGACAT Forward 146 
 Receptor IIA  TACCTTCGTGTGCCAACCTG Reverse  
ActRIIB Activin NM_204317.1 CGTGACCATCGAAGAGTGCT Forward 130 
 Receptor IIB  CACGATGGAGACAAGGCAGT Reverse  
ALK4 Activin-like XM_001231300.3 CCGCTACACGGTGACCATAG Forward 107 
 Kinase 4  TCCCAGGCTTTCCCTGAGTA Reverse  
ALK5 Actvin-like NM_204246.1 GGCAGAGCTGTGAGGCATTA Forward 73 
 Kinase 5  CTAGCAGCTCCGTTGGCATA Reverse  
AMPKα1 AMP activated NM_001039603.1 CCACCCCTGTACCGGAAATA Forward 68 
 Kinase  1  GGAAGCGAGTGCCAGAGTTC Reverse  
AMPKα2 AMP activated 
 
NM_001039605.1 TGTAAGCATGGACGTGTTGAAGA Forward 62 
 Kinase  2  GCGGAGAGAATCTGCTGGAA Reverse  
CAV-3 Caveolin-3 NM_204370.2 CGTTGTAAAGGTGGATTTCGAGG Forward 110 
   ACCAGTACTTGCTGACGGTG Reverse  
CK(m) Creatine Kinase NM_205507.1 TGGGTTACATCCTGACGTGC Forward 101 
 (muscle isoform)  CTCCTCGAATTTGGGGTGCT Reverse  
FSTN Follistatin NM_205200.1 CCCGGGCATGCTCGTA Forward 60 
   TGCGCTGTGTGATCTTCCAT Reverse  
GLUT-8 Glucose NM_204375.1 GGCATCGTGGTTTGGGTCTA Forward 73 
 Transporter-8  ATCCACAAGGTAGCCTCCCA Reverse  
HSP-70 Heat Shock JO2579 GGGAGAGGGTTGGGCTAGAG Forward 55 
 Protein 70  TTGCCTCCTGCCCAATCA Reverse  
IDE Insulin Degrading XM_421686.5 GCCCATTTGCTTACGTGGAT Forward 77 
 Enzyme  GTTGAGGGAGTCTTTGAGTAGTTCAA Reverse  
IGF-1 Insulin-like NM_001004384.2 GCTGCCGGCCCAGAA Forward 56 
 Growth Factor 1  ACGAACTGAAGAGCATCAACCA Reverse  
IGFBP-3 IGF-1 NM_001101034.1 ATCAGGCCATCCCAAGCTT Forward 59 
 Binding Protein  GATGTGCTGTGGAGGCAAATT Reverse  
 
  
1
0
7
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Table 4.1 (Cont’d). 
Gene 
Symbol 
Gene  
Name  
Accession Numbera Primer Sequence (5’ ➔ 3’) Orientation Product 
Size (bp) 
IRS-1 Insulin Receptor NM_005544.2 GCGCAAGGTGGGCTACCT Forward 64 
 Substrate 1  CGCGCGCAGTACGAAGA Reverse  
MAP2K6 Mitogen activated XM_003642348.2 TGTCTCAGTCGAGAGGCAAA Forward 105 
 Kinase kinase 6  TGGAGTCTAGATCCCTGGGT Reverse  
MAP3K7 Mitogen activated XM_004940375.1 CCTGATGATGCAGGTAAGACCA Forward 107 
 Protein kinase 7  TCTTTGGAGTTCGGGCATGG Reverse  
MSTN Myostatin NM_001001461.1 ATGCAGATCGCGGTTGATC Forward 59 
   GCGTTCTCTGTGGGCTGACT Reverse  
mTOR Mechanistic target XM_417614.5 CATGTCAGGCACTGTGTCTATTCTC Forward 77 
 of rapamycin  CTTTCGCCCTTGTTTCTTCACT Reverse  
MYOG Myogenin NM_204184.1 GGAGAAGCGGAGGCTGAAG Forward 62 
   GCAGAGTGCTGCGTTTCAGA Reverse  
MYOZ2 Myozenin NM_001277827.1 CAACACTCAGCAACAGAGGC Forward 120 
   GTATGGGCTCTCCACGATTTCT Reverse  
NCF2 Neutrophil XM_004943279.1 TCTTTGCTTGCGAGGTGGT Forward 111 
 Cytosolic Factor 2  TTTCTGGTGTCTTGGGCCTG Reverse  
P70S6K 70 kDa ribosomal NM_001109771.2 GTCAGACATCACTTGGGTAGAGAAAG Forward 60 
 Protein S6 kinase  ACGCCCTCGCCCTTGT Reverse  
PRKAR1A cAMP dependent NM_001007845.1 GTGGGAGCGCCTTACTGTAG Forward 119 
 Kinase I  CAGCTGTGCCCTCCAAGATA Reverse  
RAPTOR Regulatory protein XM_004946275.1 GGCTACGAGCTCTGGATCTG Forward 70 
 of mTOR  TGACATGACAAGCTAACTGCC Reverse  
SHC-1 SHC-transforming NM_001293280.1 CTGCTCAAGCAGGAAGAGAGAAA Forward 110 
 Protein 1  GCGTGTCTTGTCCACGTTCT Reverse  
SMAD2 Mothers against NM_204561.1 TGAGTATAGGCGGCAGACCG Forward 107 
 Decapentaplegic 
homolog 2 
 AAGGGGAGCCCATCTGAGTC Reverse  
SMAD3 Mothers against NM_204475.1 CCCACCGTTGGACGATTACA Forward 99 
 Decaplegic homolog 
3 
 GGAGGAGGTGTCTCTGGGAT Reverse  
18S  AF173612 TCCCCTCCCGTTACTTGGAT Forward 60 
   GCGCTCGTCGGCATGTA Reverse  
 
 
 
1
0
8
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Table 4.2 Expression of eukaryotic translation elongation and initiation factors list obtained 
from an RNAseq dataset of breast muscle tissue (from Bottje et al., 2017) showing log2 high 
feed efficiency – log2 low feed efficiency (M), the gene symbol and the gene name. A negative 
or positive M value indicates expression was numerically lower or higher in the high feed 
efficiency phenotype compared to the low feed efficiency phenotype. Of the 56 sequences that 
were detected, 43 were higher (positive M value) in the high feed efficiency phenotype and 13 
were lower (negative M value) in the high FE compared to the low FE phenotype.  The skew in 
the high FE phenotype was significant (binomial P value = 0.0002). 
   M Symbol Entrez Gene Name      
         
-0.67 EEF1A1 eukaryotic translation elongation factor 1 alpha 1   
-0.18 EIF6 eukaryotic translation initiation factor 6    
-0.17 EIF4A2 eukaryotic translation initiation factor 4A2   
-0.15 EIF2AK2 eukaryotic translation initiation factor 2 alpha kinase 2  
-0.11 EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3  
-0.10 EIF3H eukaryotic translation initiation factor 3 subunit H   
-0.07 EIF3E eukaryotic translation initiation factor 3 subunit E   
-0.07 EIF3M eukaryotic translation initiation factor 3 subunit M   
-0.05 EIF2AK1 eukaryotic translation initiation factor 2 alpha kinase 1  
-0.05 EIF4H eukaryotic translation initiation factor 4H   
-0.04 EIF3L eukaryotic translation initiation factor 3 subunit L   
-0.03 EIF4A3 eukaryotic translation initiation factor 4A3   
-0.01 EIF4ENIF1 eukaryotic translation initiation factor 4E nuclear import factor 1 
0.00 EIF2S3 eukaryotic translation initiation factor 2 subunit gamma  
0.00 EIF3A eukaryotic translation initiation factor 3 subunit A   
0.02 EEF1AKMT1 eukaryotic translation elongation factor 1 alpha lysine methyltransferase 1 
0.04 EEF2 eukaryotic translation elongation factor 2   
0.05 EEF1A1 eukaryotic translation elongation factor 1 alpha 1   
0.05 EIF2B5 eukaryotic translation initiation factor 2B subunit epsilon  
0.05 EIF4E eukaryotic translation initiation factor4E    
0.06 EIF3I eukaryotic translation initiation factor 3 subunit I   
0.06 EIF4G2 eukaryotic translation initiation factor 4 gamma 2   
0.06 EIF5A2 eukaryotic translation initiation factor 5A2   
0.07 EIF2B1 eukaryotic translation initiation factor 2B subunit alpha  
0.08 EIF4E3 eukaryotic translation initiation factor 4E family member 3  
0.10 EIF1B eukaryotic translation initiation factor 1B   
0.10 EIF3B eukaryotic translation initiation factor 3 subunit B   
0.11 EIF2D eukaryotic translation initiation factor 2D   
0.11 EIF3F eukaryotic translation initiation factor 3 subunit F   
0.12 CTIF cap binding complex dependent translation initiation factor  
0.12 EIF4E2 eukaryotic translation initiation factor 4E family member 2  
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Table 4.2 (Cont’d). 
   M Symbol Entrez Gene Name      
0.14 
 
 
EIF2AK4 eukaryotic translation initiation factor 2 alpha kinase 4  
0.14 HBS1L 
HBS1 like translational 
GTPase     
0.17 EIF4G3 eukaryotic translation initiation factor 4 gamma 3   
0.17 TPT1 tumor protein, translationally-controlled 1   
0.18 EIF1AY eukaryotic translation initiation factor 1A, Y-linked   
0.19 EIF1 eukaryotic translation initiation factor 1    
0.19 EIF3D eukaryotic translation initiation factor 3 subunit D   
0.21 EIF2B2 eukaryotic translation initiation factor 2B subunit beta  
0.21 EIF4G1 eukaryotic translation initiation factor 4 gamma 1   
0.22 EEF1D eukaryotic translation elongation factor 1 delta   
0.22 EIF2B3 eukaryotic translation initiation factor 2B subunit gamma  
0.23 MTO1 mitochondrial tRNA translation optimization 1   
0.24 EIF2B1 eukaryotic translation initiation factor 2B subunit alpha  
0.24 EIF5 eukaryotic translation initiation factor 5    
0.25 EIF2B4 eukaryotic translation initiation factor 2B subunit delta  
0.26 TMA16 translation machinery associated 16 homolog   
0.28 EIF2A eukaryotic translation initiation factor 2A   
0.28 EIF2S1 eukaryotic translation initiation factor 2 subunit alpha  
0.28 EIF5B eukaryotic translation initiation factor 5B   
0.29 EEF1B2 eukaryotic translation elongation factor 1 beta 2   
0.32 EIF3J eukaryotic translation initiation factor 3 subunit J   
0.33 MTIF2 mitochondrial translational initiation factor 2   
0.41 EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1  
0.43 MTIF3 mitochondrial translational initiation factor 3   
0.45 MTRF1 mitochondrial translational release factor 1   
0.61 MSS51 MSS51 mitochondrial translational activator   
0.66 MTRF1L mitochondrial translational release factor 1 like   
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Figure 4.1 Differentially expressed genes that are involved in muscle development and 
differentiation in breast muscle from Pedigree Male (PedM) broilers exhibiting high or low feed 
efficiency (FE) phenotype.   Relative expression of mRNA is shown for myogenin (A), 
myozenin-2 (B), mitogen activated protein kinase kinase 6 (MAP2K6) (C), MAP kinase kinase 
kinase 7 (MAP3K7) (D), caveolin 3 (CAV-3) (E), heat shock protein 70 (HSP70) (F), and 
neutrophil cytosolic factor 2 (NCF2) (G). Bars represent the mean ± SE (n=5).  Mean values 
were different at P ≤ 0.05 (*) or P ≤ 0.01 (**). 
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Figure 4.2 Differentially expressed genes that are involved in myostatin signaling in breast 
muscle from Pedigree Male (PedM) broilers exhibiting high or low feed efficiency (FE) 
phenotype. Relative expression of mRNA is shown for myostatin (A), follistatin (B), activin 
receptor type IIA and IIB (ActIIA and Act IIB) (C,D), Mothers against decapentaplegic homolog 
2 and 3 (SMAD2 and SMAD3) (E, F), and activin receptor-like kinase 4 and 5 (ALK 4 and ALK 
5) (G, H). Bars represent the mean ± SE (n=5). Mean values were different at P ≤ 0.05 (*), P ≤ 
0.01 (**), or P < 0.001. 
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Figure 4.3 Myostatin signaling in muscle cells. Myostatin initially binds to one of the two 
activin type II receptors, and then binds to one or both of the activin-like kinase type I receptors 
4 and 5 (ALK 4,5). Binding with myostatin activates the ALK4 and ALK 5 type I receptors 
resulting in phosphorylation of the transcription factors SMAD 2,3 that leads to inhibition of 
muscle growth and differentiation. Gene expression of the molecules shown in green were 
downregulated in the high FE phenotype (upregulated in the low FE phenotype) whereas 
molecules in gray were not differentially expressed between the groups. The figure is adapted 
from Lee and Glass (2011). 
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Figure 4.4 Differentially expressed genes that are involved in A) muscle metabolism (energy 
sensing/storage), and B) protein synthesis via nutrient sensing in breast muscle from Pedigree 
Male (PedM) broilers exhibiting high or low feed efficiency (FE) phenotype. Relative expression 
of mRNA is shown for AMP-activated protein kinase alpha subunits 1 and 2 (AMPKα1 and 
AMPKα2), creatine kinase muscle isoform (CKM), regulatory-associated protein of mTOR 
(RAPTOR), mechanistic target of rapamycin (mTOR), and 70 kDa ribosomal protein S6 kinase 
(P70S6K). Bars represent the mean ± SE (n=5). Mean values were different at P ≤ 0.05 (*), P ≤ 
0.01 (**), P < 0.001 (***). 
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Figure 4.5 Gene expression associated with the insulin signaling pathway in breast muscle from 
Pedigree Male (PedM) broilers exhibiting high or low feed efficiency (FE) phenotype. Relative 
expression of mRNA is shown for; A) insulin receptor (IR), B) insulin receptor substrate 1 (IRS-
1), C) SHC-transforming protein 1 (SHC-1), D) insulin-like growth factor-binding protein 3 
(IGFBP-3), E) glucose transporter 8 (GLUT-8), and F) cAMP-dependent protein kinase type I-
alpha regulatory subunit (PRKAR1A). Bars represent the mean ± SE (n=5). Mean values were 
different at P ≤ 0.05 (*) or P ≤ 0.01 (**). 
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Figure 4.6 Diagrammatic representation of targeted gene expression analysis conducted in the 
present study combined with information obtained from results from global protein and gene 
expression studies [7, 8].  Genes expression that would enhance muscle development in the high 
FE phenotype include the upregulation of Myog (Myogenin), Map3K7, Map2K6, and NCF2 and 
down regulation of CAV3 and Smad 2,3.  Map4k4 was not differentially expressed in the present 
study but was predicted to be inhibited in a proteomic study [7] (Kong et al., 2016).  Components 
that would potentially enhance protein synthesis include Raptor and eukaryotic translation and 
initiation complex expression (see Table 2) and components supporting ribosome assembly and 
mRNA translation (see Bottje et al., [8]).  Although upregulation of AMPK in high FE would 
presumably inhibit protein synthesis, stimulation of mitochondrial biogenesis through 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1) (see Kong et al. 
[7]) and enhanced energetic infrastructure and creatine kinase shuttle expression (Bottje et al., 
[47]) could provide ATP needed to support protein synthesis in high FE breast muscle. The 
downregulation of Glut 8 and PRKAR1A that are involved in glycolysis and lipolysis, 
respectively, appears to not be compatible with the elevation of AMPK in the high FE PedM 
phenotype.
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5.1 ABSTRACT 
The major objective of this study was to assess the expression of mitochondrial hormone receptors 
for progesterone (PR), estrogen (ER), glucocorticoid (GR), thyroid (TR), and insulin (IR) in avian 
muscle cells (quail muscle 7, QM7) and in breast muscle of quail and broilers. Visualization of 
receptor location in QM7 cells was accomplished by immunofluorescence. QM7 cells were stained 
with Mito Tracker Deep Red CMX, fixed in methanol, immune stained with anti-PR, -GR, -TR, -
IR, and -ER primary antibodies overnight at 4°C, and visualized with Alexa Fluor 488-conjugated 
secondary antibody. After staining the nucleus with 4',6-diamidino-2-phenylindole (DAPI), 
images were obtained by immunofluorescence microscopy. Merged images revealed the presence 
of all five hormone receptors on mitochondria in QM7 cells.  Western blot analysis identified; a) 
the -isoform of the PR, b) the -isoform of GR, c) the −receptor of TR, d) the −subunit of IR, 
and e) the -isoform of the ER on mitochondria isolated from broiler breast muscle. Similar results 
were obtained in quail breast muscle mitochondria with the exception that the -isoform of the 
GR was not detected.  To our knowledge, this is the first report of hormone receptors (PR, TR, 
GR, IR, and ER) on mitochondria in avian cells.  We hypothesize that these receptors could play 
important roles in regulating mitochondrial function in avian muscle cells. 
 
 
 
 
 
 
Key Words: mitochondrial hormone receptors, muscle cells, steroid hormones, thyroid hormone, 
insulin. 
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5.2 INTRODUCTION 
 Steroid hormones, thyroid hormone, and insulin are well known to influence fundamental 
cellular and organismal processes such as metabolism, growth, and development.  There is 
accumulating evidence in mammals that these hormones may act on mitochondria by two 
general mechanisms.  The first is an indirect mechanism in which the hormone is conveyed to 
the nucleus where it binds to hormone response elements followed by cell signaling that, among 
other cell processes, enhance mitochondrial protein transcription, mitochondrial biogenesis and 
subsequently, mitochondrial function (see reviews by Wrutniak-Cabello et al. 2001; Chen et al., 
2005; Psarra et al. 2006).  In the second mechanism, the hormone binds directly to mitochondrial 
receptors to initiate effects on mitochondria gene expression and function (e.g. Tsiriyotis et al., 
1997; Psarra, et al. 2008; Du et al. 2009; Dai et al. 2013; Feng et al., 2014).  
 From global gene and global protein expression studies conducted in muscle tissue, we 
have evidence that several hormones and/or hormone receptors including progesterone, estrogen, 
thyroid hormone, corticosterone, and components of insulin signaling are associated with the 
phenotypic expression of feed efficiency in a Pedigree Male broiler line (Bottje et al., 2012; 
2016; Kong et al., 2011; 2016). Progesterone receptor and two other transcription factors 
involved in progesterone signaling were identified as having a major impact on phenotypic 
expression of feed efficiency (Bottje et al., 2017).  This latter finding is somewhat curious as 
these studies were conducted in immature male broiler breeders in which endogenous 
progesterone levels would not typically be considered as having major effects on cell function.   
Studies investigating progesterone receptors in mammalian mitochondria have shown 
that the hormone plays a role in controlling oxidative phosphorylation during periods of high 
metabolic activity or in metabolically active tissues (Dai et al., 2013; Price and Dai, 2015). The 
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binding of hormones to mitochondrial receptors stimulates the activation of transcription factors 
and genes encoding components of the oxidative phosphorylation system, which increases 
mitochondrial biogenesis and the capacity for cellular respiration (Psarra et al., 2006). 
Progesterone and estrogen reduced mitochondrial reactive oxygen species production and 
oxidative damage in brain cells (Irwin et al. 2008).  Pretreatment of animals with progesterone 
reduced the effects of traumatic brain injury by preserving mitochondrial function in nerve tissue 
(Robertson and Sarawati, 2015). Progesterone was also effective in maintaining mitochondrial 
function by initiating transcription when the hormone-receptor complex binds to hormone-
response elements located on both nuclear and mitochondrial DNA (Psarra et al., 2006). 
Although mitochondrial hormone receptors have been identified in mammalian tissues, to 
our knowledge, there are no reports of avian mitochondrial hormone receptors. The presence of 
hormone receptors in avian mitochondria would give additional insight into how mitochondrial 
function is controlled and if this might related to genetic traits such as feed efficiency. Therefore, 
the purpose of this study is to determine if mitochondrial hormone receptors for progesterone, 
estrogen, glucocorticoid, thyroid, and insulin are present in both an avian muscle cell line and 
intact avian muscle tissues. 
5.3 MATERIALS AND METHODS 
5.3.1 ANIMALS AND BREAST MUSCLE TISSUE COLLECTION 
 Breast muscle tissue used in this study was obtained from male Cobb-500 broilers and 
male Japanese quail. The animals used in this study were raised under standard conditions, with 
a standard diet and provided access to feed and water ad libitum. Birds were humanely 
euthanized, breast muscle tissue (Pectoralis major) was quickly excised and flash frozen in 
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liquid nitrogen, and stored at -80 C º. All procedures for animal care complied with the 
University of Arkansas Institutional Animal Care and Use Committee (IACUC Protocols #13039 
and #14012). 
5.3.2 CELL CULTURE 
 Quail muscle 7 (QM7) cells were grown in cell culture medium M199 (ThermoFisher, 
Life Technologies, Grand Island, NY) supplemented with 10% FBS (Life Technologies), 10% 
tryptose phosphate broth (Sigma-Aldrich, St. Louis, MO), and 1% penicillin-streptomycin (Life 
Technologies) at 37°C under a humidified atmosphere of 95% air and 5% CO2 as previously 
described (Lassiter et al., 2015). 
5.3.3 SEPARATION OF NUCLEAR, CYTOPLASMIC, AND MITOCHONDRIAL 
COMPONENTS 
 Nuclear and cytoplasmic proteins were extracted from QM7 cells and breast muscle using 
the Membrane, Nuclear, & Cytoplasmic Protein Extraction Kit (BSP002) (Bio Basic Inc., 
Ontario, Canada), according to the manufacturer’s recommendations. Mitochondria were isolated 
from QM7 cells and broiler/quail breast muscle using Thermo Scientific Mitochondria Isolation 
Kits 89874 and 89801(Pierce Biotechnology, Rockford, IL), respectively, according to the 
manufacturer’s recommendations. 
5.3.4 ANTIBODIES 
Immunofluorescence assessment of mitochondrial hormone receptors in QM7 cells utilized 
affinity purified rabbit polyclonal antibodies for anti-progesterone receptor (PR), anti-estrogen 
receptor (ER), anti-glucocorticoid receptor (GR), anti-thyroid hormone receptor (TR), and anti-
insulin receptor (IR) used in this study were obtained from Santa Cruz Biotechnology (Dallas, 
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TX). The anti-PR was raised against a peptide mapping at the C-terminus of PR of human origin, 
and the anti-GR was raised against a peptide mapping at the C-terminus of GRα of human origin. 
The anti-TR was raised against amino acids 1 to 408 that represents the full length TRα1 of chicken 
origin, yet this antibody is able to detect both α and β isoforms. The anti-IR was raised against 
amino acids 128 to 205 that represents the α-isoform of human origin.  
With the exception of the TR polyclonal antibody, initial studies revealed extensive non-
specific binding of polyclonal antibodies for the remaining hormone receptors in breast muscle 
tissue. Thus, monoclonal antibodies were used to detect the PR, IR, and GR hormone receptors in 
broiler and quail breast muscle by Western blot analysis. Protein G purified mouse monoclonal 
anti-estrogen receptor (ER) (Thermo Fisher Scientific, Rockford, IL) was raised against the C-
terminus (aa 302-595) of human ER expressed in E. coli. Mouse monoclonal anti-IR and anti-GR 
(Santa Cruz Biotechnology, Dallas, TX) were raised against the C-terminus of IR of human origin 
and amino acids 121-420 of GR of human origin, respectively. The protein G purified mouse 
monoclonal anti-PR (Abcam Inc., Cambridge, MA) was raised against PR originating from chick 
oviduct cytosol.  
To verify the separation of mitochondria from cytosolic and nuclear compartments, western 
analysis was conducted on each cell fraction using polyclonal antibodies (Cell Signaling 
Technology Inc., Danvers MA) for: a) the 32 kDa voltage-dependent anion channel (VDAC) 
protein found exclusively in mitochondria (Columbini et al., 1996), b) the 75 kDa glucose 
regulated protein 75 (GRP-75), a protein found in the mitochondria and cytosol, but not in the 
nucleus, (Mizzen et al., 1991; Mazkereth et al., 2016), c) glyceraldehyde 3 phosphate 
dehydrogenase (GAPDH) located primarily in the cytosol (Lodish et al., 2000), and d) the 110 
kDa phosphoprotein nucleolin that is expressed in the nucleolus (Tutega and Tutega, 1999). The 
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VDAC protein was detected using protein A/peptide affinity chromatography-purified polyclonal 
antibody for human VDAC (Cell Signaling Technology Inc., Danvers, MA).  GRP-75 was 
detected with a human GRP-75 monoclonal antibody (Thermo Fisher Scientific, Waltham MA). 
GAPDH was detected using a polyclonal anti-GAPDH raised against amino acids 1-335 that 
represent full length GAPDH of human origin (Santa Cruz Biotechnology, Dallas, TX). 
Nucleolin was detected using a polyclonal anti-nucleolin raised against amino acids 271-520 of 
nucleolin of human origin (Santa Cruz Biotechnology, Dallas, TX). 
5.3.5 IMMUNOFLUORESCENCE 
 QM7 cells were grown to 50-60% confluence in chamber slides (Lab-Tek, Hatfield, PA) 
and stained with Mitotracker® deep red CMX dye (dihydro-X-rosamine, ThermoFisher, 
Molecular Probes, Life Technologies, Grand Island, NY) according to manufacturer 
specifications.  The MitoTracker dye passively diffuses across the cell membrane and 
accumulate in active mitochondria. The cells were then fixed in methanol for 10 min at -20°C 
with protein block serum-free blocking buffer (Dako, Carpinteria, CA). The cells were then 
incubated with rabbit anti-PR, anti-GR, anti-TR, anti-IR,  (1:200; Santa Cruz Biotechnology, 
Dallas, TX) or mouse anti-ER (Thermo Fisher Scientific, Rockford, IL) overnight at 4°C and 
visualized with Alexa Fluor 488-conjugated secondary antibody (Molecular Probes, Life 
Technologies). The slides were counterstained with 4',6-diamidino-2-phenylindole (DAPI) and 
cover-slipped in Vectashield (Vector Laboratories, Burlingame, CA). Fluorescent images were 
obtained using a Zeiss Imager M2 microscope (Carl Zeiss Microscopy, LLC, Thornwood, NY) 
with an attached CCD camera (Hamamatsu, Orca ER, Bridgewater, NJ), and Image-Pro Plus 
software (Media Cybernetics, Inc., Rockville, MD). 
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5.3.6 PROTEIN EXPRESSION 
 QM7 cells and breast muscle tissue were homogenized in RIPA buffer (Pierce 
Biotechnology) containing Halt™ Protease & Phosphatase Inhibitor Cocktail (EDTA-free, Pierce 
Biotechnology). Protein concentrations were determined using a Synergy HT multimode 
microplate reader (BioTek, Winooski, VT) and a Bradford assay kit (Bio-Rad, Hercules, CA) 
with BSA as a standard. Proteins (ranging from 30 to 125 µg loaded on the gel) were separated 
on 10% Mini-PROTEAN® TGX™ gels (Bio-Rad). The separated proteins were transferred to 
PVDF membranes, blocked for 1 h at room temperature, and incubated with primary antibodies 
(dilutions ranging from 1:100 to 1:1000) at 4°C overnight. Due to non-specific binding observed 
with polyclonal antibodies, monoclonal antibodies (mouse anti-ER, anti-PR, anti-IR, and anti-
GR) were used for western analysis. A pre-stained molecular weight marker (Precision Plus 
Protein Dual Color) was used as a standard (Bio-Rad).  The PVDF membranes were incubated 
with the HRP-conjugated secondary antibody (1:5000) (Cell Signaling Technology) for 1 h at 
room temperature. The signal was visualized by enhanced chemiluminescence (ECL plus) (GE 
Healthcare Bio-Sciences, Pittsburgh, PA) and captured by FluorChem M MultiFluor System 
(ProteinSimple, San Jose, CA). Image acquisition was performed using AlphaView software 
(ProteinSimple). 
5.3.7 IMMUNOPRECIPITATION 
 Immunoprecipitation was performed prior to detection of the ER in order to reduce 
incidences of non-specific binding by the primary antibody observed in pilot studies. The 
primary antibody was first conjugated to Dynabeads™ M-280 Tosylactivated magnetic beads 
using a DynaMag™-2 magnet (Thermo Fisher Scientific, Rockford, IL) following the 
manufacturer’s instructions. The antibody-coupled beads were mixed with the protein sample 
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and incubated at 35°C for 30-40 min to capture the specific target protein. The bead-antibody-
protein complex was resuspended in Laemmli sample buffer before proceeding directly to 
Western blotting. 
5.4 RESULTS 
5.4.1 IMMUNOFLUORESCENCE IMAGING 
 Immunofluorescence imaging of QM7 cells is presented in Figure 1. In the third panel for 
each hormone, functional mitochondria were evident in the QM7 myoblast cells as indicated by 
their ability to import MitoTracker Red into the organelles.   The yellow-orange color in the 
merged images in the fourth panel indicates that hormone receptors were co-localized on 
mitochondria of QM7 cells. 
5.4.2 WESTERN BLOT ANALYSIS 
To verify that the mitochondrial fraction did not contain nuclear proteins, western analysis 
was conducted on each of the cell fractions for GRP-75, VDAC, and GAPDH (Figure 2).  Clear 
separation of the mitochondrial from the nuclear fraction is shown in Figure 2A by the absence of 
binding to GRP-75 and VDAC1.   GAPDH was primarily detected in the cytoplasmic fraction with 
a small amount present in the nuclear fraction and a faint detection in the mitochondrial fraction 
(Figure 2B).  There was no band present in the mitochondrial fraction at the appropriate molecular 
weight for nucleolin (110 kDa) but there was considerable non-specific binding in bands below 
100 kDa (data not shown).   
The presence of a specific isoform, subunit, or receptor for each mitochondrial hormone receptor 
at the target molecular weight was determined for all five hormones examined in broilers (Figure 
3) and for PR, TR, IR and ER in quail (Figure 4).  It is worth mentioning that the gel provided in 
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the product description for the GR antibody provided by the company (Santa Cruz 
Biotechnology) indicated the presence of two bands between approximately 90 to 110 kDa and 
the gel was cutoff below 80 kDa.  Thus, the second band shown in Figure 3b could either be the 
result of non-specific binding or possibly the presence of a receptor protein fragment.  No 
literature citation was provided for this gel, so we assume it was conducted by the company.  A 
second band at ~ 30 to 32 kDa in the ER blot (Figure 3e) was also present in the background 
information on the ER antibody obtained from Thermo Fisher.   In quail muscle, several bands in 
addition to the  isoform band of PR was apparent (Figure 4a).  A very gel image was presented 
in the background information for the Thermo Fisher PR antibody. 
5.5 DISCUSSION 
The economic impact of feed efficiency has been illustrated in production animal 
agriculture (e.g. Emmerson 1997; Robinson and Oddy, 2004; Patience et al., 2015).  Commercial 
broilers have been highly selected for growth and feed efficiency when compared to previous, less 
intensely-selected lines of birds (Zuidhof et al., 2014). Progesterone was reported to play a role in 
the phenotypic expression of feed efficiency in pedigree male broilers (Bottje et al., 2017).  
Progesterone was also predicted to be activated in the high feed efficiency pedigree male broiler 
phenotype based on downstream target protein expression (Kong et al., 2016). As mammalian 
mitochondria receptors for many hormones including progesterone (Tsiriyotis et al., 1997; Psarra, 
et al. 2008; Du et al. 2009; Dai et al. 2013; Feng et al., 2014), we initiated studies to determine if 
mitochondrial hormone receptors for progesterone, estrogen, glucocorticoid, thyroid hormone, and 
insulin were present in avian muscle cells in vitro and in vivo.  To our knowledge, this is the first 
time that mitochondrial hormone receptors have been reported in any avian tissue or species.  
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The binding of progesterone to its receptor is typically associated with the physiological 
role in the reproductive function of females; i.e. development of the mammary glands and uterus, 
ovarian function, and sexual behavior (Connelly and Lydon, 2000). The progesterone-receptor 
complex functions as a transcription factor through its binding to hormone response elements in 
the nucleus, and the activation of Src signaling pathways in the cytoplasm that promote cell 
proliferation, cell differentiation and mitochondrial function (Edwards et al., 2003).  Using rat 
brain mitochondria, Irwin et al. (2008) reported that progesterone-treated mitochondria exhibited 
increased cytochrome c oxidase activity, reduced oxidative damage, and enhanced antioxidant 
protection. Dai et al. (2013) demonstrated that treating cells with progestin increased cellular 
respiration and mitochondrial membrane potential. Therefore, the action of progesterone signaling 
appears to be beneficial to mitochondrial function, and supports findings in recent proteogenomic 
studies (Kong et al., 2016; Bottje et al., 2017). 
 The glucocorticoid receptor is a part of the superfamily of nuclear receptors (Psarra et al., 
2006). The presence of glucocorticoid receptors in the mitochondria of mammalian cells has been 
clearly shown using immunofluorescence and immunogold electron microscopy (Scheller et al., 
2000). There have been a number of reports illustrating how the presence of glucocorticoid 
receptors affect mitochondrial activity and the regulation of energy production. When HepG2 cells 
were stably transfected to overexpress mitochondrial-targeted glucocorticoid receptors, these cells 
showed an increase in RNA synthesis, expression of the mitochondrial protein cytochrome oxidase 
subunit I, and mitochondrial ATP production (Psarra and Sekeris, 2011). Treating rat skeletal 
muscle and C2C12 muscle cells with dexamethasone, a synthetic glucocorticoid, was shown to 
stimulate mitochondrial biogenesis (Weber et al., 2002).  In a recent study, Morgan et al. (2016) 
suggested that a specific isoform of the glucocorticoid receptor (GRγ) is specialized in regulating 
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mitochondrial function, causing an increase in oxygen consumption, ATP production, and 
mitochondrial mass. Steroid receptors are translocated to the mitochondria following hormonal 
stimulation (Psarra et al., 2006). Translocation of the glucocorticoid receptor to the mitochondria 
is thought to occur by its interaction with chaperone proteins such as HSP70 (Du et al., 2009). 
Therefore, mitochondrial glucocorticoid receptors in avian muscle cells may play a role in 
regulating mitochondrial function and energy production.   
 Thyroid hormone plays a significant role in energy metabolism. This occurs when the 
hormone response element is activated by binding of the ligand-receptor complex, affecting 
transcription of both nuclear and mitochondrial genes that encode for subunits of the mitochondrial 
oxidative phosphorylation system (Scheller et al., 2003; Psarra and Sekeris, 2008). Due to this 
ability to interact with DNA binding sites that modulate gene and protein expression, the thyroid 
hormone receptor functions as a ligand-activated transcription factor (Psarra et al., 2006). Several 
isoforms of the thyroid hormone receptor are present in mammalian cells. The variation in number 
and position of amino acids in these isoforms can determine whether ligand binding promotes or 
inhibits transcription (Bassett et al., 2003). Two truncated thyroid receptor α isoforms (p28 and 
p43) that specifically targeted to the mitochondria increase mitochondrial gene expression, 
oxidative phosphorylation, and thermogenesis (Bassett et al., 2003). The p43 isoform is of 
particular interest since it is located in the mitochondrial matrix, and therefore in direct contact 
with the hormone response elements of mitochondrial DNA (Wrutniak et al., 1995). Interestingly, 
studies in which QM7 cells were transfected to overexpress p43 showed that mitochondrial activity 
was stimulated by this receptor isoform (Casas et al., 1999; Rochard et al., 2000). Based on the 
molecular weight of the thyroid receptor detected in our study which corresponds to the β isoform, 
it is not likely to be one of these mitochondria-specific isoforms. However, it is possible that this 
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β isoform is associated with non-genomic actions linked to secondary messenger signaling 
pathways (i.e. protein kinase and Ca2+ pathways) to elicit a hormone response (Losel and Wehling, 
2003). 
 In the present study, immunofluorescence microscopy demonstrated that the insulin 
receptor co-localized with mitochondria in QM7 cells (Figure 1D), and that the -subunit precursor 
was detected in the mitochondrial fraction of broiler (Figure 3D) and quail breast muscle (Figure 
4C). However, a search of the literature does not indicate that the insulin receptor is located on the 
mitochondrial membrane. A relationship between mitochondrial function and insulin resistance 
has been reported (Montgomery and Turner, 2015). In neurons, signaling between the insulin 
receptor and mitochondria occurs through the generation of reactive oxygen species in the 
mitochondria, primarily via succinate oxidation (Pomytkin, 2012). The insulin receptor belongs to 
the family of receptor tyrosine kinases, where ligand binding stimulates a phosphorylation cascade 
that help regulate cell metabolism, proliferation, and differentiation. Recent studies have shown 
that certain members of the receptor tyrosine kinase family translocate to the mitochondria where 
the phosphorylation of mitochondrial proteins regulates metabolism and function (Ding et al., 
2012; Salvi 2013). In the review by Lemmon and Schlessinger (2010), the extracellular structural 
domain of the human insulin receptor is very similar to that of the epidermal growth factor receptor 
(EGFR) which another receptor tyrosine kinase member that is known to translocate to the 
mitochondria (Salvi et al., 2005). The extracellular domains of both the EGFR and insulin receptor 
subfamilies contain large amounts of leucine and cysteine regions (Lemmon and Schlessinger, 
2010).  
 In summary, the results of this study indicate that the avian muscle cells and breast 
muscle tissue express mitochondrial hormone receptors for progesterone, glucocorticoid, thyroid 
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hormone, and insulin.   We hypothesize that the steroid hormones investigated in the current 
study could have direct effects on mitochondrial function in avian muscle through binding to 
specific mitochondrial hormone receptors and may play fundamentally important roles in avian 
physiology and genetic phenotypes. 
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5.7 FIGURES 
 
Figure 5.1 Immunofluorescent staining of QM7 cells for visualization of mitochondrial receptors for; A) Progesterone, B) 
Glucocorticoid, C) Thyroid, D) Insulin and E) Estrogen. The nucleus was visualized with DAPI (blue), cytoplasm with Alexafluor 
(green), and mitochondria with Mitotracker® deep red CMX (red). The merged images with orange to yellow coloring represents the 
presence of mitochondrially located hormone receptors.  
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Figure 5.2 Verification of cell fractionation procedures. Gels are shown for A) Nucleolin (C23) 
(110 kDa) that was detected in nuclear fraction but not the mitochondrial fraction.  B) Voltage 
dependent activation channel (VDAC) that was detected in the mitochondrial fraction only, and 
C) Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) – present primarily in the cytoplasmic 
fraction but not in the mitochondrial fraction. 
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Figure 5.3 Hormone receptor expression in mitochondria isolated from breast muscle obtained from broiler for; (A) progesterone, (B) 
glucocorticoid, (C) thyroid hormone, (D) insulin, and (E) estrogen. The amount of protein loaded onto the gel for each lane was 75 µg.
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Figure 5.4 Hormone receptor expression in mitochondria isolated from breast muscle obtained 
from Japanese Quail for;  (A) progesterone, (B) thyroid, (C) insulin, and (D) estrogen. The 
amount of protein loaded onto the gel for each lane was 75 µg. 
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6. CONCLUSIONS 
 In this dissertation the expression of hormones and hormone receptors as it relates to 
mitochondrial function and feed efficiency in broilers was investigated. Hormonal action plays 
an important role in maintaining cellular function and contributing to muscle development and 
growth. However, studies of the relationship between hormones, mitochondria, and muscle have 
largely been confined to mammalian species; with very little information being present 
concerning avian species. Therefore, the overall goal of research in this dissertation was to 
determine if the hormone orexin is present in avian muscle cells and affects mitochondrial 
physiology, investigate whether differences in the feed efficiency of broilers can be partially 
attributed to differences in the expression of components of hormone signaling pathways, and to 
determine whether hormone receptors are present within the mitochondria of avian muscle cells.  
 We found that the neuropeptide orexin and its related receptors indeed are expressed in 
both intact avian muscle cells and an immortalized avian muscle cell line. Not only is orexin 
present, but is also secreted by these muscle cells, indicating that avian muscle tissue may use the 
hormone in an autocrine or paracrine role. The application of recombinant orexin impacted the 
expression of a number of genes involved in mitochondrial fission/fusion and metabolism. This 
study provides the first evidence of the orexin system being involved in avian muscle function. 
Based on these findings, future studies can be developed to investigate how other hormones and 
their receptors, particularly steroid and thyroid hormones, participate in the regulation of growth 
and mitochondrial function of avian muscle. 
 While investigating orexin in avian muscle, concurrent analysis of the high and low feed 
efficient broiler phenotype was also performed. Breast muscle isolated from both groups of birds 
was subjected to global gene and protein expression analysis. Based on the data obtained from 
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those studies, genes involved in regulating muscle hypertrophy as well as the insulin signaling 
pathway were predicted to be determinants of the high feed efficient phenotype. Using these 
predictions as a guideline, real-time qPCR was performed on breast muscle samples from both 
groups to investigate genes involved in muscle development and hypertrophy, in addition to 
insulin signaling. The results indicated that a number of genes involved in enhancing muscle 
growth and formation (i.e. AMPK, myogenin, creatine kinase) were upregulated in the high feed 
efficient phenotype, whereas genes known to inhibit muscle hypertrophy, differentiation, and 
fiber size (i.e. myostatin, caveolin-3, IGFBP-3) were downregulated in the high feed efficient 
phenotype. Additionally, several genes that are members of the insulin signaling pathway were 
differentially expressed between the two phenotypes, though no clear pattern was established. It 
must be noted that the insulin signaling pathway is very complex and not fully understood in 
mammalian species, even less so in avian species. Therefore future studies to elucidate the 
intricacies of the insulin pathway in avian species is warranted. This may lead to a better 
understanding of how the pathway is involved in muscle growth, mitochondrial function, and the 
determination of the high/low feed efficient phenotype.      
In the previous global protein expression analysis it was predicted that enhanced 
progesterone signaling within the mitochondria is a characteristic of the high feed efficient 
phenotype. Even though the presence of hormone receptors and hormone response elements have 
been identified in mammalian mitochondria, the same cannot be said for avian species. In the 
final study of this dissertation we were able to identify receptors for progesterone, estrogen, 
glucocorticoids, thyroid, and insulin in broiler and quail breast muscle tissue and an 
immortalized avian muscle cell line. Since the presence of hormone receptors has been shown to 
enhance energy production and gene/protein expression in mammalian mitochondria, in future 
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studies it would be interesting to compare levels of mitochondrial hormone receptor expression 
between the high and low feed efficient phenotypes to determine whether it can be classified as a 
defining trait of feed efficiency in these animals.  
The increasing global demand for animal protein coupled to the increasing costs of 
animal production makes feed efficiency a very important topic. The more researchers are able to 
understand about the physiology of these animals then the more likely we are to have the ability 
to implement changes that have a positive impact on the poultry industry.     
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APPENDIX 
In regard to IACUC protocols #13039 and #14012, the student (Kentu R. Lassiter) was not 
involved in the animal care or harvesting of tissues used for the collection of research data. 
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